RADIATION CONTROL - LICENSING OF RADIOACTIVE MATERIAL

ColoradoRegulations

Ask Donna

How this section applies to your facts.

Code of Colorado Regulations › 1000 Department of Public Health and Environment › 1007 Hazardous Materials and Waste Management Division › 6 CCR 1007-1 Part 03

This text was captured on Sep 30, 2026. It is a snapshot, not a live feed, so check the official code before relying on it.

Text

_________________________________________________________________________

Adopted by the Board of Health on October 18, 2023; effective December 15, 2023.

LICENSING OF RADIOACTIVE MATERIAL

3.1

Purpose and Scope

3.1.1

Authority.

3.1.1.1 Rules and regulations set forth herein are adopted pursuant to the provisions of sections

25-1-108, 25-1.5-101(1)(k) and (1)(l), and 25-11-104, CRS.

3.1.2

Basis and Purpose.

3.1.2.1 A statement of basis and purpose of these regulations is incorporated as part of these

regulations; a copy may be obtained from the Department.

3.1.3

Scope.

3.1.3.1 This part, and Parts 5, 7, 14, 16, 17, 18, and 19 of these regulations, provide for the

licensing of radioactive material.

3.1.3.2 No person shall receive, possess, own, acquire, process, use, store, transfer, or dispose

radioactive material except as authorized pursuant to this part or Parts 5, 7, 14, 17, 18, or

19 of these regulations, or as otherwise provided in these parts.

3.1.4

Applicability.

3.1.4.1 In addition to the requirements of this part, all licensees are subject to the requirements

of Parts 1, 4, 10, 12 and 17.

3.1.4.2 Furthermore:

(1)

Licensees engaged in industrial radiographic operations are subject to the

requirements of Part 5.

(2)

Licensees using radionuclides in the healing arts are subject to the requirements

of Part 7.

(3)

Licensees engaged in land disposal of radioactive material are subject to the

requirements of either Part 14 or Part 18, as appropriate.

(4)

Licensees engaged in source material milling are subject to the requirements of

Part 18.

(5)

Licensees engaged in wireline and subsurface tracer studies are subject to the

requirements of Part 16.

(6)

Panoramic or underwater irradiator licensees are subject to the requirements of

Part 19.

Published material incorporated by reference.

3.1.4.3 Throughout this Part 3, federal regulations, state regulations, and standards or guidelines

of outside organizations have been adopted and incorporated by reference. Unless a

prior version of the incorporated material is otherwise specifically indicated, the materials

incorporated by reference cited herein include only those versions that were in effect as

of the most recent effective date of this Part 3 (December 2023), and not later

amendments or editions of the incorporated material.

3.1.4.4 Materials incorporated by reference are available for public inspection, and copies

(including certified copies) can be obtained at reasonable cost, during normal business

hours from the Colorado Department of Public Health and Environment, Hazardous

Materials and Waste Management Division, 4300 Cherry Creek Drive South, Denver,

Colorado 80246. Additionally, https://cdphe.colorado.gov/hm/radregs identifies where the

incorporated federal and state regulations are available to the public on the internet at no

cost. A copy of the materials incorporated in this Part is available for public inspection at

the state publications depository and distribution center.

3.1.4.5 Availability from Source Agencies or Organizations.

(1)

All federal agency regulations incorporated by reference herein are available at

no cost in the online edition of the Code of Federal Regulations (CFR) hosted by

the U.S. Government Printing Office, online at

https://www.govinfo.gov/app/collection/cfr/.

(2)

All state regulations incorporated by reference herein are available at no cost in

the online edition of the Code of Colorado Regulations (CCR) hosted by the

Colorado Secretary of State’s Office, online at

https://www.sos.state.co.us/CCR/Welcome.do.

3.1.5

Definitions

3.1.5.1 Definitions of general applicability to these regulations are in Part 1, Section 1.2.

3.1.5.2 As used in Part 3, each term below has the definition set forth.

“Consortium” means an association of medical use licensees and a Positron Emission

Tomography (PET) radionuclide production facility in the same geographical area that

jointly own or share in the operation and maintenance cost of the PET radionuclide

production facility that produces PET radionuclides for use in producing radioactive drugs

within the consortium for noncommercial distributions among its associated members for

medical use. The PET radionuclide production facility within the consortium must be

located at an educational institution or a Federal facility or a medical facility.

3.1.6

The Department may engage the services of qualified persons in order to assist the Department

in meeting the requirements of these regulations, including, but not limited to, evaluating

information that may be required under 3.8.8.

3.1.6.1 Fees for these services may be charged by the Department as a part of fees charged for

radiation control services under Part 12.

EXEMPTIONS FROM THE REGULATORY REQUIREMENTS

3.2

Exemption Of Source Material

3.2.1

Any person is exempt from this part to the extent that such person receives, possesses, uses,

owns, or transfers source material in any chemical mixture, compound, solution, or alloy in which

the source material is by weight less than 1/20th of 1 percent (0.05 percent) of the mixture,

compound, solution, or alloy.

3.2.2

Any person is exempt from this part to the extent that such person receives, possesses, uses, or

transfers unrefined and unprocessed ore containing source material; provided that, except as

authorized in a specific license, such person shall not refine or process such ore.

3.2.3

Any person is exempt from this part to the extent that such person receives, possesses, uses, or

transfers an item containing uranium or thorium listed in Schedule 3C, Sections 3C.1 through

3C.10.

3.2.3.1 The exemptions listed in Schedule 3C do not authorize the manufacture of any of the

products described.

3.3

Exemption Of Radioactive Material Other Than Source Material.

3.3.1

Exempt Concentrations.

3.3.1.1 Except as provided in 3.3.1.2, any person is exempt from this part to the extent that such

person receives, possesses, uses, transfers, or acquires products containing radioactive

material introduced in concentrations not in excess of those listed in Schedule 3A.

(1)

A manufacturer, processor, or producer that transfers a product or material is

exempt so long as concentrations less than those listed in schedule 3A were

introduced under an NRC license so authorizing.

(2)

Transfer of radioactive material contained in any food, beverage, cosmetic, drug,

or other commodity or product designed for ingestion or inhalation by, or

application to, a human being, is not exempt under 3.3.1.1(1).

3.3.1.2 No person may introduce radioactive material into a product or material knowing or

having reason to believe that it will be transferred to persons exempt under 3.3.1.1 or

equivalent regulations of NRC or any Agreement State, except in accordance with a

specific license issued consistent with 3.12.1 or the general license provided in 3.24.

3.3.2

Exempt Quantities.

3.3.2.1 Except as provided in 3.3.2.3 and 3.3.2.4, any person is exempt from these regulations to

the extent that such person receives, possesses, uses, transfers, owns, or acquires

radioactive material in individual quantities each of which does not exceed the applicable

quantity set forth in Schedule 3B.

3.3.2.2 Any person who possesses radioactive material received or acquired under the general

license formerly provided under 10 CFR Part 31.4 before September 25, 1971 is exempt

from the requirements for a license set forth in this part to the extent that such person

possesses, uses, transfers or owns such radioactive material.

3.3.2.3 Section 3.3.2 does not authorize the production, packaging or repackaging of radioactive

material for purposes of commercial distribution, or the incorporation of radioactive

material into products intended for commercial distribution.

3.3.2.4 No person may, for purposes of commercial distribution, transfer radioactive material in

the individual quantities set forth in Schedule 3B, knowing or having reason to believe

that such quantities of radioactive material will be transferred to persons exempt under

3.3.2 or equivalent regulations of NRC or any Agreement State except in accordance with

a specific license issued by NRC pursuant to Section 32.18 of 10 CFR Part 32, which

license states that the radioactive material may be transferred by the licensee to persons

exempt under 3.3.2 or the equivalent regulations of NRC or an Agreement State.1

1 Authority to transfer possession or control by the manufacturer, processor, or producer of any equipment, device, commodity, or

other product containing byproduct material whose subsequent possession, use, transfer, and disposal by all other persons are

exempted from regulatory requirements may be obtained only from the U.S. Nuclear Regulatory Commission, Washington, D.C.

20555.

3.3.2.5 No person may, for purposes of producing an increased radiation level, combine

quantities of radioactive material covered by this exemption so that the aggregate

quantity exceeds the limits set forth in Schedule 3B, except for a device placed in use

before May 3, 1999, or as otherwise permitted by these regulations.

3.3.3

Exempt Items.

3.3.3.1 Any person is exempt from this part to the extent that such person receives, possesses,

uses, or transfers an item containing radioactive material which is listed in Schedule 3C,

Sections 3C.11 through 3C.14.

LICENSES

3.4

Types of Licenses.

Licenses for radioactive materials are of two types: general and specific.

3.4.1

A general license is provided by regulation and grants authority to a person for certain activities

involving radioactive material.

3.4.1.1 A general license is effective without the filing of an application with the Department or

the issuance of a licensing document to a particular person.

3.4.1.2 However, registration or filing of a certificate with the Department may be required by the

particular general license.

3.4.1.3 The general licensee is subject to all other applicable portions of these regulations and

any limitations of the general license.

3.4.2

A specific license requires the submission of an application to the Department and the issuance

of a licensing document by the Department.

3.4.2.1 The licensee is subject to all applicable portions of these regulations as well as any

limitations specified in the licensing document.

GENERAL LICENSES

3.5

General Licenses – Small Quantities Of Source Material.

3.5.1

A general license is hereby issued authorizing commercial and industrial firms; research,

educational and medical institutions; and Federal, State and local government agencies to

receive, possess, use and transfer uranium and thorium, in their natural isotopic concentrations

and in the form of depleted uranium, for research, development, educational, commercial, or

operational purposes in the following forms and quantities:

3.5.1.1 No more than 1.5 kg (3.3 lb) of uranium and thorium in dispersible forms (e.g., gaseous,

liquid, powder, etc.) at any one time. Any material processed by the general licensee that

alters the chemical or physical form of the material containing source material must be

accounted for as a dispersible form. A person authorized to possess, use, and transfer

source material under 3.5.1.1 may not receive more than a total of 7 kg (15.4 lb) of

uranium and thorium in any one calendar year. Persons possessing source material in

excess of these limits as of August 27, 2016, may continue to possess up to 7 kg (15.4

lb) of uranium and thorium at any one time for one year beyond this date, or until the

Department takes final action on a pending application submitted on or before August 27,

2017, for a specific license for such material; and receive up to 70 kg (154 lb) of uranium

or thorium in any one calendar year until December 31, 2017, or until the Department

takes final action on a pending application submitted on or before August 27, 2017, for a

specific license for such material; and

3.5.1.2 No more than a total of 7 kg (15.4 lb) of uranium and thorium at any one time. A person

authorized to possess, use, and transfer source material under 3.5.1.2 may not receive

more than a total of 70 kg (154 lb) of uranium and thorium in any one calendar year. A

person may not alter the chemical or physical form of the source material possessed

under 3.5.1.2 unless it is accounted for under the limits of 3.5.1.1; or

3.5.1.3 No more than 7 kg (15.4 lb) of uranium, removed during the treatment of drinking water,

at any one time. A person may not remove more than 70 kg (154 lb) of uranium from

drinking water during a calendar year under 3.5.1.3; or

3.5.1.4 No more than 7 kg (15.4 lb) of uranium and thorium at laboratories for the purpose of

determining the concentration of uranium and thorium contained within the material being

analyzed at any one time. A person authorized to possess, use, and transfer source

material under 3.5.1.4 may not receive more than a total of 70 kg (154 lb) of source

material in any one calendar year.

3.5.2

Any person who receives, possesses, uses or transfers source material in accordance with the

general license in 3.5.1:

3.5.2.1 Is prohibited from administering source material, or the radiation therefrom, either

externally or internally, to human beings except as may be authorized by the Department,

NRC, or an Agreement State in a specific license.

3.5.2.2 Shall not abandon such source material. Source material may be disposed of as follows:

(1)

A cumulative total of 0.5 kg (1.1 lb) of source material in a solid, non-dispersible

form may be transferred each calendar year, by a person authorized to receive,

possess, use, and transfer source material under this general license to persons

receiving the material for permanent disposal. The recipient of source material

transferred under the provisions of this paragraph is exempt from the

requirements to obtain a license under this part to the extent the source material

is permanently disposed. This provision does not apply to any person who is in

possession of source material under a specific license issued under this chapter;

or

(2)

In accordance with 4.33.

3.5.2.3 Is subject to the provisions in 3.1, 3.14.2, 3.15.1 through 3.15.3, 3.15.2.1, 3.15.4.2,

through 3.15.4.4, 3.22, 3.23, 4.40, 4.50, 4.52, and 10.5.1.

3.5.2.4 Shall respond to written requests from the Department to provide information relating to

the general licensee within 30 calendar days of the date of the request, or other time

specified in the request. If the person cannot provide the requested information within the

allotted time, the person shall, within that same time period, request a longer period to

supply the information by providing the Department a written justification for the request;

3.5.2.5 Shall not export such source material except in accordance with a license issued by NRC

pursuant to 10 CFR Part 110.

3.5.3

Any person who receives, possesses, uses, or transfers source material in accordance with 3.5.1

shall conduct activities so as to minimize contamination of the facility and the environment. When

activities involving such source material are permanently ceased at any site, if evidence of

significant contamination is identified, the general licensee shall notify the Department about such

contamination and may consult with the Department as to the appropriateness of sampling and

restoration activities to ensure that any contamination or residual source material remaining at the

site where source material was used under this general license is not likely to result in exposures

that exceed the limits in 4.61.2.

3.5.4

Any person who receives, possesses, uses, or transfers source material in accordance with the

general license granted in 3.5.1 is exempt from the provisions of Parts 4 and 10 to the extent that

such receipt, possession, use, and transfer are within the terms of such general license, except

that such person shall comply with the provisions of 4.61.2 and 4.33 to the extent necessary to

meet the provisions of 3.5.2.2 and 3.5.3. However, this exemption does not apply to any person

who also holds a specific license issued under Part 3.

3.5.5

No person may initially transfer or distribute source material to persons generally licensed under

3.5.1.1 or 3.5.1.2, or equivalent regulations of an Agreement State or NRC, unless authorized by

a specific license issued in accordance with 3.22.6 or equivalent provisions of an Agreement

State or NRC. This prohibition does not apply to analytical laboratories returning processed

samples to the client who initially provided the sample. Initial distribution of source material to

persons generally licensed under 3.5.1 before August 27, 2016, without specific authorization

may continue for 1 year beyond this date. Distribution may also be continued until the Department

takes final action on a pending application for license or license amendment to specifically

authorize distribution submitted on or before August 27, 2017.

3.5.6

A general license is hereby issued authorizing the receipt of title to source material without regard

to quantity.

3.5.6.1 This general license does not authorize any person to receive, possess, use, or transfer

source material.

3.5.7

A general license is hereby issued authorizing the possession of source material involved in

mining operations provided such operations meet the regulatory requirements of the Division of

Reclamation, Mining and Safety, Colorado Department of Natural Resources, or any successor

thereto, and, except as authorized in a specific license, such mining operations shall not refine or

process such ore.

3.5.8

Depleted Uranium in Industrial Products and Devices.

3.5.8.1 A general license is hereby issued to receive, acquire, possess, use, or transfer, in

accordance with the provisions of 3.5.8.2, 3.5.8.3, and 3.5.8.4, depleted uranium

contained in industrial products or devices for the purpose of providing a concentrated

mass in a small volume of the product or device.

3.5.8.2 The general license in 3.5.8.1 applies only to industrial products or devices which have

been manufactured either in accordance with a specific license issued to the

manufacturer of the products or devices pursuant to 3.12.13 or in accordance with a

specific license issued to the manufacturer by the NRC or an Agreement State which

authorizes manufacture of the products or devices for distribution to persons generally

licensed by the NRC or an Agreement State.

(1)

Persons who receive, acquire, possess, or use depleted uranium pursuant to the

general license established by 3.5.8.1 shall file Department Form R-52,

“Registration Certificate - Use of Depleted Uranium Under General License”, with

the Department.

(a)

The form shall be submitted within 30 days after the first receipt or

acquisition of such depleted uranium.

(b)

The general licensee shall furnish on Department Form R-52 the

following information and such other information as may be required by

that form:

(i)

Name and address of the general licensee;

(ii)

A statement that the general licensee has developed and will

maintain procedures designed to establish physical control over

the depleted uranium described in 3.5.8.1 and designed to

prevent transfer of such depleted uranium in any form, including

metal scrap, to persons not authorized to receive the depleted

uranium; and

(iii)

Name and title, address, and telephone number of the individual

duly authorized to act for and on behalf of the general licensee in

supervising the procedures identified in 3.5.8.2(1)(b)(ii).

(2)

The general licensee possessing or using depleted uranium under the general

license established by 3.5.8.1 shall report in writing to the Department any

changes in information previously furnished using Department Form R-52,

“Registration Certificate - Use of Depleted Uranium Under General License”. The

report shall be submitted within 30 days after the effective date of such change.

3.5.8.3 A person who receives, acquires, possesses, or uses depleted uranium pursuant to the

general license established by 3.5.8.1:

(1)

Shall not introduce such depleted uranium, in any form, into a chemical, physical,

or metallurgical treatment or process, except a treatment or process for repair or

restoration of any plating or other covering of the depleted uranium;

(2)

Shall not abandon such depleted uranium;

(3)

Shall transfer or dispose of such depleted uranium only by transfer in accordance

with the provisions of 3.22.

(a)

In the case where the transferee receives the depleted uranium pursuant

to the general license established by 3.5.8.1, the transferor shall furnish

the transferee a copy of this regulation and a copy of Department Form

R-52.

(b)

In the case where the transferee receives the depleted uranium pursuant

to a general license contained in NRC's or Agreement State's regulation

equivalent to 3.5.8.1, the transferor shall furnish the transferee a copy of

this regulation and a copy of Department Form R-52 accompanied by a

note explaining that use of the product or device is regulated by NRC or

Agreement State under requirements substantially the same as those in

this regulation;

(4)

Within 30 days of any transfer, shall report in writing to the Department the name

and address of the person receiving the depleted uranium pursuant to such

transfer, and

(5)

Shall not export such depleted uranium except in accordance with a license

issued by NRC pursuant to 10 CFR Part 110.

3.5.8.4 Any person receiving, acquiring, possessing, using, or transferring depleted uranium

pursuant to the general license established by 3.5.8.1 is exempt from the requirements of

Parts 4 and 10 with respect to the depleted uranium covered by that general license.

3.6

General Licenses2 - Radioactive Material Other Than Source Material.

2 Different general licenses are issued in this section, each of which has its own specific conditions and requirements.

3.6.1

Reserved.

3 Reserved

3.6.2

Reserved.

3.6.3

Reserved.

3.6.4

Certain Measuring, Gauging or Controlling Devices.

3.6.4.1 A general license is hereby issued to commercial and industrial firms and to research,

educational and medical institutions, individuals in the conduct of their business, and

State or local government agencies to receive, acquire, possess, use or transfer, in

accordance with the provisions of 3.6.4.2, 3.6.4.3, and 3.6.4.4, radioactive material,

excluding special nuclear material, contained in devices designed and manufactured for

the purpose of detecting, measuring, gauging or controlling thickness, density, level,

interface location, radiation, leakage, or qualitative or quantitative chemical composition,

or for producing light or an ionized atmosphere.

3.6.4.2 The general license in 3.6.4.1 applies only to radioactive material contained in devices

which have been:

(1)

Manufactured or initially transferred and labeled for distribution to persons

generally licensed in accordance with the specifications contained in a specific

license issued by:

(a)

The Department pursuant to 3.12.4 or

(b)

The NRC or an Agreement State4

4 Regulations under the Federal Food, Drug, and Cosmetic Act authorizing the use of radioactive control devices in food production

require certain additional labeling thereon which is found in 21 CFR 179.21.

(2)

Received from one of the specific licensees described in 3.6.4.2(1) or through a

transfer made under 3.6.4.3(8).

3.6.4.3 Any person who owns, receives, acquires, possesses, uses, owns, or transfers

radioactive material in a device pursuant to the general license in 3.6.4.1:

(1)

Shall assure that all labels affixed to the device at the time of receipt, and bearing

a statement that removal of the label is prohibited, are maintained thereon and

shall comply with all instructions and precautions provided by such labels;

(2)

Shall assure that the device is tested for leakage of radioactive material and

proper operation of the “on-off” mechanism and indicator, if any, at no longer

than 6-month intervals or at such other intervals as are specified in the label,

however;

(a)

Devices containing only krypton need not be tested for leakage of

radioactive material; and

(b)

Devices containing only tritium or not more than 3.7 MBq (100 µCi) of

other beta- and/or gamma-emitting material or 0.37 MBq (10 µCi) of

alpha-emitting material and devices held in storage in the original

shipping container prior to initial installation need not be tested for any

purpose.

(3)

Shall assure that the tests required by 3.6.4.3(2) of this section and other testing,

installation, servicing, and removal from installation involving the radioactive

material, its shielding or containment, are performed:

(a)

In accordance with the instructions provided by the labels; or

(b)

By a person holding an applicable specific license from the Department,

NRC or an Agreement State to perform such activities;

(4)

Shall maintain records showing compliance with the requirements of 3.6.4.3(2)

and 3.6.4.3(3).

(a)

The records shall show the results of tests.

(b)

The records also shall show the dates of performance of, and the names

of persons performing, testing, installation, servicing, and removal from

installation concerning the radioactive material, its shielding or

containment.

(c)

Records of tests for leakage of radioactive material required by 3.6.4.3(2)

shall be maintained for 3 years after the next required leak test is

performed or until the sealed source is transferred or disposed of.

(d)

Records of tests of the “on-off” mechanism and indicator required by

3.6.4.3(2) shall be maintained for 3 years after the next required test of

the “on-off” mechanism and indicator is performed or until the sealed

source is transferred or disposed of.

(e)

Records which are required by 3.6.4.3(3) shall be maintained for a period

of 3 years from the date of the recorded event or until the device is

transferred or disposed of;

(5)

Upon the occurrence of a failure of or damage to, or any indication of a possible

failure of or damage to, the shielding of the radioactive material or the “on-off”

mechanism or indicator, or upon the detection of 185 Bq (0.005 µCi) or more

removable radioactive material, shall immediately suspend operation of the

device and shall:

(a)

Not operate the device until it has been repaired by the manufacturer or

other person holding an applicable specific license from the Department,

NRC or an Agreement State to repair such devices;

(b)

Ensure that, if dispositioned, the device and any radioactive material

from the device is disposed of by transfer to a person authorized by an

applicable specific license to receive the radioactive material contained

in the device;

(c)

Within 30 days, furnish to the Department a report containing a brief

description of the event and the remedial action taken; and

(d)

In the case of detection of 185 Bq (0.005 microcurie) or more removable

radioactive material or failure of or damage to a source likely to result in

contamination of the premises or the environs, furnish to the Director of

the Hazardous Materials And Waste Management Division, within 30

days, a plan for ensuring that the premises and environs are acceptable

for unrestricted use.

(i)

Under these circumstances, the criteria set out in 4.61.2,

“Radiological Criteria For Unrestricted Use,” may be applicable,

as determined by the division on a case by case basis;

(6)

Shall not abandon the device containing radioactive material;

(7)

Shall not export the device except in accordance with 10 CFR Part 110 and shall

obtain written approval from NRC before transferring the device to any other

specific licensee not specifically identified in 3.6.4.3(8);

(8)

Except as provided in 3.6.4.3(9), shall transfer or dispose of the device

containing radioactive material:

(a)

Only by transfer to a specific licensee of the Department, NRC or an

Agreement State whose specific license authorizes receipt of the device;

and

(b)

Within 30 days after transfer or export, shall furnish to the Department a

report containing:

(i)

Identification of the device by manufacturer's (or initial

transferor’s) name, model number and serial number;

(ii)

The name, address and license number of the person receiving

the device;

(iii)

The date of the transfer;

(iv)

The identity of the radionuclide(s) present and activity present,

by assay or calculation;

(c)

Shall obtain written Department approval before transferring the device

to any other specific licensee not specifically identified in 3.6.4.3(8).

However, a holder of a specific license may transfer a device for

possession and use under its own specific license without prior approval,

if, the holder:

(i)

Verifies that the specific license authorizes the possession and

use, or applies for and obtains an amendment to the license

authorizing the possession and use;

(ii)

Removes, alters, covers, or clearly and unambiguously

augments the existing label (otherwise required by 3.6.4.3(1) of

this part) so that the device is labeled in compliance with Part 4,

Section 4.30; however the manufacturer, model number, and

serial number must be retained;

(iii)

Obtains the manufacturer’s or initial transferor’s information

concerning maintenance that would be applicable under the

specific license (such as leak testing procedures); and

(iv)

Reports the transfer under 3.6.4.3(8)(b).

(9)

Shall transfer the device to another general licensee only:

(a)

Where the device remains in use at a particular location.

In such case the transferor shall give the transferee a copy of this

regulation and any safety documents identified in the label on the device

and within 30 days of the transfer, report to the Department the

manufacturer's (or initial transferor’s) name and model number and serial

number of device transferred, the identity of the radionuclide(s) present

and assayed or calculated activity present, the transferee’s name and

mailing address for the location of use, and the name, title, and phone

number of the responsible individual identified by the transferee in

accordance with 3.6.4.3(12) to have knowledge of and authority to take

actions to ensure compliance with the appropriate regulations and

requirements; or

(b)

Where the device is held in storage by an intermediate person in the

original shipping container at its intended location of use prior to initial

use by a general licensee; and

(10)

Shall comply with the provisions of 4.51 and 4.52 for reporting radiation incidents,

theft, or loss of licensed material, but shall be exempt from the other

requirements of Parts 4 and 10;

(11)

Shall respond to written requests from the Department to provide information

relating to the general license within 30 calendar days of the date of the request,

or other time specified in the request.

(a)

If the general licensee cannot provide the requested information within

the allotted time, it shall, within that same time period, request a longer

period to supply the information by providing the director of the

Hazardous Materials and Waste Management Division a written

justification for the request;

(12)

Shall appoint an individual responsible for having knowledge of the appropriate

regulations and requirements and the authority for taking required actions to

comply with appropriate regulations and requirements.

(a)

The general licensee, through this individual, shall ensure the day-to-day

compliance with appropriate regulations and requirements; this

appointment does not relieve the general licensee of any of its

responsibility in this regard;

(13)

Shall register each device annually in accordance with 3.6.4.3(13)(a) and

3.6.4.3(13)(b), and shall pay the fee required by Part 12, if in possession of a

device containing at least 370 MBq (10 mCi) of cesium-137, 3.7 MBq (0.1 mCi) of

strontium-90, 37 MBq (1 mCi) of cobalt-60, 3.7 MBq (0.1 mCi) of radium-226, or

37 MBq (1 mCi) of americium 241 or any other transuranic (i.e., element with

atomic number greater than uranium (92)), based on the activity indicated on the

label. Each address for a location of use, as described in 3.6.4.3(13)(b)(iv) of this

section, represents a separate general licensee and requires a separate

registration and fee.

(a)

Registration must be done by verifying, correcting, and/or adding to the

information provided in a request for registration received from the

Department.

(i)

The registration information must be submitted to the

Department within 30 days of the date of the request for

registration or as otherwise indicated in the request.

(b)

In registering devices, the general licensee shall furnish the following

information and any other information specifically requested by the

Department:

(i)

Name and mailing address of the general licensee;

(ii)

Information about each device: the manufacturer (or initial

transferor), model number, serial number, the radioisotope and

activity (as indicated on the label);

(iii)

Name, title, and telephone number of the responsible person

designated as a representative of the general licensee under

3.6.4.3(12);

(iv)

Address or location at which the device(s) are used and/or

stored; for portable devices, the address of the primary place of

storage;

(v)

Certification by the responsible representative of the general

licensee that the information concerning the device(s) has been

verified through a physical inventory and checking of label

information; and

(vi)

Certification by the responsible representative of the general

licensee that they are aware of the requirements of the general

license.

(c)

A general licensee holding devices meeting the criteria of 3.6.4.3(13) is

subject to the bankruptcy notification requirement in 3.15.5.

(d)

Persons generally licensed by an Agreement State with respect to

devices meeting the criteria in paragraph 3.6.4.3(13) are not subject to

U.S. Nuclear Regulatory Commission registration requirements if the

devices are used in areas subject to NRC jurisdiction for a period less

than 180 days in any calendar year. The Commission will not request

registration information from such licensees.

(14)

Shall report changes to the mailing address for the location of use (including

change in name of general licensee) to the director of the hazardous materials

and waste management division within 30 days of the effective date of the

change.

(a)

For a portable device, a report of address change is only required for a

change in the device's primary place of storage.

(15)

May not hold a device that is not in use for longer than 2 years.

(a)

If a device with shutters is not being used, the shutter must be locked in

the closed position.

(b)

The testing required by 3.6.4.3(2) need not be performed during the

period of storage only.

(c)

However, when a device is put back into service or transferred to another

person, and has not been tested within the required test interval, the

device must be tested for leakage before use or transfer and the shutter

tested before use.

(d)

A device kept in standby for future use is excluded from the two-year

time limit if the general licensee performs quarterly physical inventories

of the device while the device is in standby.

3.6.4.4 The general license in 3.6.4.1 does not authorize the manufacture of devices containing

radioactive material.

3.6.4.5 The general license provided in 3.6.4.1 is subject to the provisions of 1.4 through 1.9,

3.15, 3.22, 3.23 and Part 17.

3.6.5

Luminous Safety Devices for Aircraft.

3.6.5.1 A general license is hereby issued to receive, acquire, possess, and use tritium or

promethium-147 contained in luminous safety devices for use in aircraft, provided:

(1)

Each device contains not more than 370 GBq (10 Ci) of tritium or 11.1 GBq (300

mCi) of promethium-147; and

(2)

Each device has been manufactured, assembled or imported in accordance with

a specific license issued by the NRC or each device has been manufactured or

assembled in accordance with the specifications contained in a specific license

issued by the Department or any Agreement State to the manufacturer or

assembler of such device pursuant to licensing requirements equivalent to those

in Section 32.53 of 10 CFR Part 32.

3.6.5.2 Persons who own, receive, acquire, possess, or use luminous safety devices pursuant to

the general license in 3.6.5.1 are exempt from the requirements of Parts 4 and 10 except

that they shall comply with the provisions of 4.51 and 4.52.

3.6.5.3 This general license does not authorize the manufacture, assembly, or repair of luminous

safety devices containing tritium or promethium-147.

3.6.5.4 This general license does not authorize the ownership, receipt, acquisition, possession or

use of promethium-147 contained in instrument dials.

3.6.5.5 This general license is subject to the provisions of 1.4 through 1.9, 3.15, 3.22, 3.23, and

Part 17.

3.6.6

Ownership of Radioactive Material.

3.6.6.1 A general license is hereby issued to own radioactive material without regard to quantity.

3.6.6.2 Notwithstanding any other provisions of this part, this general license does not authorize

the manufacture, production, transfer, receipt, possession or use of radioactive material.

3.6.7

Calibration and Reference Sources.

3.6.7.1 A general license is hereby issued to those persons listed below to own, receive, acquire,

possess, use, and transfer, in accordance with the provisions of 3.6.7.4 and 3.6.7.5,

americium-241 in the form of calibration or reference sources:

(1)

Any person who holds a specific license issued by the Department which

authorizes receipt, possession, use, and transfer of radioactive material; and

(2)

Any person who holds a specific license issued by the NRC which authorizes

receipt, possession, use, and transfer of special nuclear material.

3.6.7.2 A general license is hereby issued to own, receive, possess, use, and transfer plutonium

in the form of calibration or reference sources in accordance with the provisions of 3.6.7.4

and 3.6.7.5 to any person who holds a specific license issued by the Department which

authorizes the licensee to receive, possess, use, and transfer radioactive material.

3.6.7.3 A general license is hereby issued to own, receive, possess, use, and transfer radium

226 in the form of calibration or reference sources in accordance with the provisions of

3.6.7.4 and 3.6.7.5 to any person who holds a specific license issued by the Department

which authorizes the licensee to receive, possess, use, and transfer radioactive material.

3.6.7.4 The general licenses in 3.6.7.1, 3.6.7.2, and 3.6.7.3 apply only to calibration or reference

sources which have been manufactured or initially transferred in accordance with the

specifications contained in a specific license issued to the manufacturer or importer of the

sources by the NRC pursuant to Section 32.57 of 10 CFR Part 32 or Section 70.39 of 10

CFR Part 70 or which have been manufactured in accordance with the specifications

contained in a specific license issued to the manufacturer by the Department or any

Agreement State pursuant to licensing requirements equivalent to those contained in

Section 32.57 of 10 CFR Part 32 or Section 70.39 of 10 CFR Part 70.

3.6.7.5 The general licenses provided in 3.6.7.1, 3.6.7.2, and 3.6.7.3 are subject to the

provisions of 1.4 through 1.9, 3.15, 3.22, 3.23 and 3.24, and Parts 4 and 10. In addition,

persons who own, receive, acquire, possess, use, or transfer one or more calibration or

reference sources pursuant to these general licenses, shall:

(1)

Not possess at any one time, at any one location of storage or use, more than

185 kBq (5 µCi) of americium-241, 185 kBq (5 µCi) of plutonium, or 185 kBq (5

µCi) of radium-226 in such sources;

(2)

Not receive, possess, use, or transfer such source unless the source, or the

storage container, bears a label which includes one of the following statements,

as appropriate, or a substantially similar statement which contains the

information called for in one of the following statements, as appropriate:

(a)

The receipt, possession, use and transfer of this source, Model ___,

Serial No.__ are subject to a general license and the regulations of the

U.S. Nuclear Regulatory Commission or an Agreement State. Do not

remove this label.

CAUTION - RADIOACTIVE MATERIAL - THIS SOURCE CONTAINS

(AMERICIUM-241) (PLUTONIUM) (RADIUM-226).5 DO NOT TOUCH

RADIOACTIVE PORTION OF THIS SOURCE.

5 Showing only the name of the appropriate material.

______________________________________

Name of manufacturer or importer

(3)

Not transfer, abandon, or dispose of such source except by transfer to a person

authorized by a license from the Department, NRC or an Agreement State to

receive the source;

(4)

Store such source, except when the source is being used, in a closed container

adequately designed and constructed to contain americium-241, plutonium, or

radium-226 which might otherwise escape during storage; and

(5)

Not use such source for any purpose other than the calibration of radiation

detectors or the standardization of other sources.

3.6.7.6 These general licenses do not authorize the manufacture, import, or export of calibration

or reference sources containing americium-241, plutonium or radium-226.

3.6.8

General license for certain items and self-luminous products containing radium-226.

3.6.8.1 A general license is hereby issued to any person to acquire, receive, possess, use, or

transfer, in accordance with the provisions of 3.6.8.2 through 3.6.8.4., radium-226

contained in the following products manufactured prior to November 30, 2007.

(1)

Antiquities originally intended for use by the general public.

For the purposes of 3.6.8.1(1), antiquities mean products originally intended for

use by the general public and distributed in the late 19th and early 20th

centuries, such as radium emanator jars, revigators, radium water jars, radon

generators, refrigerator cards, radium bath salts, and healing pads.

(2)

Intact timepieces containing greater than 0.037 MBq (1 µCi), nonintact

timepieces, and timepiece hands and dials no longer installed in timepieces.

(3)

Luminous items installed in air, marine, or land vehicles.

(4)

All other luminous products, provided that no more than 100 items are used or

stored at the same location at any one time.

(5)

Small radium sources containing no more than 0.037 MBq (1 µCi) of radium-226.

For the purposes of 3.6.8.1(5), ‘‘small radium sources’’ means discrete survey

instrument check sources, sources contained in radiation measuring instruments,

sources used in educational demonstrations (such as cloud chambers and

spinthariscopes), electron tubes, lightning rods, ionization sources, static

eliminators, or as designated by the NRC.

3.6.8.2 Persons who acquire, receive, possess, use, or transfer radioactive material under the

general license issued in 3.6.8.1 are exempt from the provisions of Parts 4 and 10 of

these regulations, to the extent that the receipt, possession, use, or transfer of

radioactive material is within the terms of the general license; provided, however, that this

exemption shall not be deemed to apply to any such person specifically licensed under

this Part.

3.6.8.3 Any person who acquires, receives, possesses, uses, or transfers radioactive material in

accordance with the general license in 3.6.8.1 shall:

(1)

Notify the Department should there be any indication of possible damage to the

product so that it appears it could result in a loss of the radioactive material. A

report containing a brief description of the event, and the remedial action taken,

must be furnished to the Department within 30 days.

(2)

Not abandon products containing radium-226. The product, and any radioactive

material from the product, may only be disposed of according to Part 4, Section

4.39.2 of these regulations or by transfer to a person authorized by a specific

license to receive the radium-226 in the product or as otherwise approved by the

NRC or an Agreement State.

(3)

Not export products containing radium-226 except in accordance with 10 CFR

Part 110.

(4)

Dispose of products containing radium-226 at a disposal facility authorized to

dispose of radioactive material in accordance with any Federal or State solid or

hazardous waste law, including the Solid Waste Disposal Act, as authorized

under the Energy Policy Act of 2005, by transfer to a person authorized to

receive radium-226 by a specific license issued under this Part, or equivalent

regulations of the NRC or an Agreement State, or as otherwise approved by the

NRC or an Agreement State.

(5)

Respond to written requests from the Department to provide information relating

to the general license within 30 calendar days of the date of the request, or other

time specified in the request. If the general licensee cannot provide the

requested information within the allotted time, it shall, within that same time

period, request a longer period to supply the information by providing the

Department, a written justification for the request.

3.6.8.4. The general license in 3.6.8.1 does not authorize the manufacture, assembly,

disassembly, repair, or import of products containing radium-226, except that timepieces

may be disassembled and repaired.

3.6.9

General License for Use of Radioactive Material for Certain In Vitro Clinical or Laboratory

Testing.6

6 The New Drug provisions of the Federal Food, Drug, and Cosmetic Act also govern the availability and use of any specific

diagnostic drugs in interstate commerce.

3.6.9.1 A general license is hereby issued to any physician, veterinarian, clinical laboratory or

hospital to receive, acquire, possess, transfer or use, for any of the following stated tests,

in accordance with the provisions of 3.6.9.2, 3.6.9.3, 3.6.9.4, 3.6.9.5, and 3.6.9.6, the

following radioactive materials in prepackaged units for use in in vitro clinical or

laboratory tests not involving internal or external administration of radioactive material, or

the radiation therefrom, to human beings or animals:

(1)

Carbon-14, in units not exceeding 370 kBq (10 µCi) each;

(2)

Cobalt-57, in units not exceeding 370 kBq (10 µCi) each;

(3)

Hydrogen-3 (tritium), in units not exceeding 1.85 MBq (50 µCi) each;

(4)

Iodine-125, in units not exceeding 370 kBq (10 µCi) each;

(5)

Mock Iodine-125 reference or calibration sources, in units not exceeding 1.85

kBq (0.05 µCi) of iodine-129 and 185 Bq (0.005 µCi) of americium-241 each;

(6)

Iodine-131, in units not exceeding 370 kBq (10 µCi) each;

(7)

Iron-59, in units not exceeding 740 kBq (20 μCi) each; or

(8)

Selenium-75, in units not exceeding 370 kBq (10 µCi) each.

3.6.9.2 No person shall receive, acquire, possess, use or transfer radioactive material pursuant

to the general license established by 3.6.9.1 until the person has filed Department Form

R-27, “Certificate - In Vitro Testing with Radioactive Material Under General License”,

with the Department and received from the Department a validated copy of Department

Form R-27 with certification number assigned. The physician, veterinarian, clinical

laboratory or hospital shall furnish on Department Form R-27 the following information

and such other information as may be required by that form:

(1)

Name and address of the physician, veterinarian, clinical laboratory or hospital;

(2)

The location of use; and

(3)

A statement that the physician, veterinarian, clinical laboratory or hospital has

appropriate radiation measuring instruments to carry out in vitro clinical or

laboratory tests with radioactive material as authorized under the general license

in 3.6.9.1 and that such tests will be performed only by personnel competent in

the use of such instruments and in the handling of the radioactive material.

3.6.9.3 A person who receives, acquires, possesses or uses radioactive material pursuant to the

general license established by 3.6.9.1 shall comply with the following requirements.

(1)

The general licensee shall not possess at any one time, pursuant to the general

license in 3.6.9.1, at any one location of storage or use, a total amount of iodine

125, iodine 131, selenium 75, iron 59, and/or cobalt 57 in excess of 7.4 MBq (200

µCi).

(2)

The general licensee shall store the radioactive material, until used, in the

original shipping container or in a container providing equivalent radiation

protection.

(3)

The general licensee shall use the radioactive material only for the uses

authorized by 3.6.9.1.

(4)

The general licensee shall not transfer the radioactive material to a person who is

not authorized to receive it pursuant to a license issued by the Department, NRC

or any Agreement State nor transfer the radioactive material in any manner other

than in the unopened, labeled shipping container as received from the supplier.

(5)

The general licensee shall dispose of the Mock Iodine 125 reference or

calibration sources described in 3.6.9.1(5) as required by 4.33.

3.6.9.4 The general licensee shall not receive, acquire, possess, or use radioactive material

pursuant to 3.6.9.1:

(1)

Except as prepackaged units which are labeled in accordance with the provisions

of an applicable specific license issued pursuant to 3.12.8 or in accordance with

the provisions of a specific license issued by the NRC or any Agreement State

which authorizes the manufacture and distribution of iodine-125, iodine-131,

carbon-14, hydrogen-3 (tritium), iron-59, selenium-75, cobalt-57, or Mock Iodine-

125 to persons generally licensed under 3.6.9 or its equivalent; and

(2)

Unless one of the following statements, as appropriate, or a substantially similar

statement which contains the information called for in one of the following

statements, appears on a label affixed to each prepackaged unit or appears in a

leaflet or brochure which accompanies the package:

(a)

This radioactive material shall be received, acquired, possessed, and

used only by physicians, veterinarians, clinical laboratories or hospitals

and only for in vitro clinical or laboratory tests not involving internal or

external administration of the material, or the radiation therefrom, to

human beings or animals. Its receipt, acquisition, possession, use, and

transfer are subject to the regulations and a general license of the U.S.

Nuclear Regulatory Commission or an Agreement State.

______________________________________

Name of manufacturer

3.6.9.5 The physician, veterinarian, clinical laboratory or hospital possessing or using radioactive

material under the general license of 3.6.9.1 shall report in writing to the Department, any

changes in the information previously furnished using the “Certificate - In Vitro Testing

with Radioactive Material Under General License”, Department Form R-27. The report

shall be furnished within 30 days after the effective date of such change.

3.6.9.6 Any person using radioactive material pursuant to the general license of 3.6.9.1 is

exempt from the requirements of Part 4 and 10 with respect to radioactive material

covered by that general license, except that such persons using the Mock Iodine-125

described in 3.6.9.1(5) shall comply with the provisions of 4.33, 4.51 and 4.52.

3.6.10 Ice Detection Devices.

3.6.10.1

A general license is hereby issued to receive, acquire, possess, use, and transfer

strontium-90 contained in ice detection devices, provided each device contains not more

than 1.85 MBq (50 µCi) of strontium-90 and each device has been manufactured or

imported in accordance with a specific license issued by NRC or each device has been

manufactured in accordance with the specifications contained in a specific license issued

by the Department or an Agreement State to the manufacturer of such device pursuant to

licensing requirements equivalent to those in Section 32.61 of 10 CFR Part 32.

3.6.10.2

Persons who own, receive, acquire, possess, use, or transfer strontium-90

contained in ice detection devices pursuant to the general license in 3.6.10.1:

(1)

Shall, upon occurrence of visually observable damage, such as a bend or crack

or discoloration from overheating to the device, discontinue use of the device

until it has been inspected, tested for leakage and repaired by a person holding a

specific license from NRC or an Agreement State to manufacture or service such

devices; or shall dispose of the device pursuant to the provisions of 4.33;

(2)

Shall assure that all labels affixed to the device at the time of receipt, and which

bear a statement which prohibits removal of the labels, are maintained thereon;

and

(3)

Are exempt from the requirements of Parts 4 and 10 except that such persons

shall comply with the provisions of 4.33, 4.51, and 4.52.

3.6.10.3

This general license does not authorize the manufacture, assembly, disassembly

or repair of strontium-90 in ice detection devices.

3.6.10.4

This general license is subject to the provisions of 1.4 through 1.9, 3.15, 3.22,

3.23 and Part 17.

ADDITIONAL EXEMPTIONS

3.7

Carriers

Common and contract carriers, freight forwarders, warehousemen, and the U.S. Postal Service

are exempt from the regulations in this Part and Parts 5, 7, 16, 19, and 22 and the requirements

for a license set forth in Section 25-11-103, CRS to the extent that they transport or store

radioactive material in the regular course of carriage for another or storage incident thereto.

SPECIFIC LICENSES

3.8

Filing An Application for A Specific License.

3.8.1

Applications for specific licenses shall be filed on a form prescribed by the Department.

3.8.2

The Department may at any time after the filing of the original application, and before the

expiration of the license, require further statements in order to enable the Department to

determine whether the application should be granted or denied or whether a license should be

modified or revoked.

3.8.3

Each application shall be signed by the applicant or licensee or a person duly authorized to act

for and on the applicant's or licensee's behalf.

3.8.4

An application for a license may include a request for a license authorizing one or more activities.

3.8.5

In the application, the applicant may incorporate by reference information contained in previous

applications, statements, or reports filed with the Department provided such references are clear

and specific.

3.8.6

Applications and documents submitted to the Department may be made available for public

inspection except that the Department may withhold any document or part thereof from public

inspection pursuant to 24-72-204, CRS.

3.8.7

Pre-licensing Construction

3.8.7.1 An application for a license, or to amend or renew an existing license, for (1) source

material milling, (2) commercial waste storage, treatment or disposal by incineration, (3)

transfer for disposal of wastes from treatment or incineration, (4) commercial waste

disposal by land burial or by underground injection, or the (5) conduct of any other activity

within the licensing authority of the Department which the Department determines will

significantly affect the radiological quality of the human environment, shall be filed with

the Department at least nine (9) months prior to the anticipated commencement of

construction of the plant or facility in which the activity will be conducted or in accordance

with the requirements of Part 18 if applicable, and shall be accompanied by the

environmental assessment required by 3.8.8, unless an exemption from the requirement

of furnishing such assessment has been obtained from the Department.

3.8.7.2 No construction shall be commenced until the license has been issued.

3.8.7.3 For the purpose of 3.8.7 the terms “construction” and “commencement of construction”,

are defined in Part 1, 1.2.

3.8.8

Environmental Assessment.

3.8.8.1 In the case of an application for a license, or to amend or renew an existing license, for

(1) source material milling, (2) commercial waste storage, treatment or disposal by

incineration, (3) transfer for disposal of waste from incineration, (4) commercial waste

disposal by land burial or by underground injection, or for (5) the conduct of any other

activity which will affect the quality of the human environment by reason of exposure to

radiation, before “commencement of construction”, as defined in 3.8.7.3, of the plant or

facility in or at which the activity will be conducted, or in case of a renewal of such a

license, the applicant shall submit all information required under these regulations and

such other material as the Department may deem necessary.

(1)

Such information shall include the environmental assessment and other

information required by 3.8.8.2 to be submitted to assist the Department in the

evaluation of the short-term and long-range environmental impact of the project

and activity so that the Department may weigh environmental, economic,

technical, and other benefits against environmental costs, while considering

available alternatives.

(2)

In the event that an environmental assessment acceptable to the Department is

on file with the Department in regard to the specific licensed activity authorized

under an existing license, and upon request of the applicant to amend or renew

an existing license or at the initiation of the Department, the Department may

grant an exemption of the requirement to submit an additional environmental

assessment or require such amendment of the existing environmental

assessment as will demonstrate the environmental impact to result from the

proposed activity.

(3)

The request for exemption shall provide the Department with such information as

the Department requires of the applicant to demonstrate that no significant

environmental impact will result from the licensed activity.

3.8.8.2 An environmental assessment shall be required of the applicant and shall contain all

information deemed necessary by the Department as required by the Act.

(1)

Upon receipt of the environmental assessment or any amendment thereto, and of

any other documents required, the Department shall determine the necessity to

transmit and, if appropriate, shall transmit the same for review and comment to

Federal, State, and local agencies having expertise in and jurisdiction over the

proposed project and activity.

(2)

Written comments and reports of reviewing agencies shall be considered by the

Department in its decision-making review process on the license application

request.

(3)

If an environmental impact statement (EIS) is required of a Federal agency

pursuant to the National Environment Policy Act of 1969 (NEPA) and is provided

by such Federal agency, it shall be used by the Department in its decision-

making review process on the license application request.

(4)

The Department shall consider applicable regulations of Federal, State, and local

regulatory agencies and permit requirements thereof.

3.8.9

Except as provided in 3.8.9.3, 3.8.9.4, and 3.8.9.5, an application for a specific license to use

radioactive material in the form of a sealed source or in a device that contains the sealed source

must either:

3.8.9.1 Identify the source or device by manufacturer and model number as registered with the

NRC under 10 CFR Part 32.210 or with an Agreement State, or for a source or a device

containing radium-226 or accelerator produced radioactive material with an Agreement

State under provisions comparable to 10 CFR Part 32.210; or

3.8.9.2 Contain the information identified in 3.12.14.3; or

3.8.9.3 For sources or devices manufactured before October 23, 2012 that are not registered

with the NRC under 10 CFR Part 32.210 or with an Agreement State, and for which the

applicant is unable to provide all categories of information specified in 3.12.14.3, the

application must include:

(1)

All available information identified in 3.12.14.3 concerning the source, and, if

applicable, the device; and

(2)

Sufficient additional information to demonstrate that there is reasonable

assurance that the radiation safety properties of the source or device are

adequate to protect health and minimize danger to life and property. Such

information must include a description of the source or device, a description of

radiation safety features, the intended use and associated operating experience,

and the results of a recent leak test.

3.8.9.4 For sealed sources and devices allowed to be distributed without registration of safety

information in accordance with 3.12.14.7(1), the applicant may supply only the

manufacturer, model number, and radionuclide and quantity.

3.8.9.5 If it is not feasible to identify each sealed source and device individually, the applicant

may propose constraints on the number and type of sealed sources and devices to be

used and the conditions under which they will be used, in lieu of identifying each sealed

source and device.

3.8.10 An application from a medical facility, educational institution, or Federal facility to produce

Positron Emission Tomography (PET) radioactive drugs for noncommercial transfer to licensees

in its consortium authorized for medical use under Part 7 of these regulations or equivalent

Agreement State requirements shall include:

3.8.10.1

A request for authorization for the production of PET radionuclides or evidence of

an existing license issued under this Part or Agreement State requirements for a PET

radionuclide production facility within its consortium from which it receives PET

radionuclides.

3.8.10.2

Evidence that the applicant is qualified to produce radioactive drugs for medical

use by meeting one of the criteria in 3.12.10.1(2).

3.8.10.3

Identification of individual(s) authorized to prepare the PET radioactive drugs if

the applicant is a pharmacy, and documentation that each individual meets the

requirements of an authorized nuclear pharmacist as specified in 3.12.10.2(2).

3.8.10.4

Information identified in 3.12.10.1(3) on the PET drugs to be noncommercially

transferred to members of its consortium.

3.9

General Requirements for the Issuance of Specific Licenses.

A license application for a specific license will be approved if the Department determines that:

3.9.1

The applicant is qualified by reason of training and experience to use the material in question for

the purpose requested in accordance with these regulations in such a manner as to minimize

danger to public health and safety or property;

3.9.2

The applicant's proposed equipment, facilities, and procedures are adequate to minimize danger

to public health and safety or property and the applicant’s facilities are permanently located in

Colorado;

3.9.3

The issuance of the license will not be inimical to the health and safety of the public;

3.9.4

The applicant satisfies any applicable special requirements in parts 3, 5, 7, 16, 19, and 22; and

3.9.5

The applicant has established Department-approved financial assurance warranties in

accordance with the following requirements.

3.9.5.1 A signed executed original copy of each warranty required by this part shall be furnished

to and approved by the Department prior to the issuance of a new license, or any

amendment or renewal of an existing license.

3.9.5.2 The Department may require any licensee to furnish a decommissioning warranty in a

dollar amount determined by the Department as necessary to protect public health and

safety, to ensure corrective action during operation, to ensure decontamination and

decommissioning of a facility and disposal of radioactive materials in the event of

abandonment, default or inability of the licensee to meet the requirements of the Act,

these regulations, or the license.

3.9.5.3 The following specific licensees are required to furnish decommissioning warranties:

(1)

Each licensee authorized to possess and use greater than 370 MBq (10 mCi) of

source material in a readily dispersible form; and

(2)

Each licensee authorized to possess and use radioactive material with a half-life

greater than 120 days, in quantities:

(a)

Greater than 103 times the applicable quantity of Schedule 3B in

unsealed form. For a combination of isotopes if R divided by 103 is

greater than 1 (unity rule), where R is defined here as the sum of the

ratios of the quantity of each isotope to the applicable value in Schedule

3B.

(b)

Greater than 1010 times the applicable quantity of Schedule 3B in sealed

sources or plated foils. For a combination of isotopes if R divided by 1010

is greater than 1 (unity rule), where R is defined in 3.9.5.3(2)(a).

(c)

370 Bq (0.01 µCi) shall be used as the Schedule 3B value for any alpha

emitting radionuclide not listed in Schedule 3B, or mixtures of alpha

emitters of unknown composition, for the purpose of determining if the

quantity of licensed radioactive material requires a decommissioning

warranty or a decommissioning funding plan as defined in 3.9.6.

(3)

Former U.S. Atomic Energy Commission or NRC licensed facilities;

(4)

Radioactive waste collection and/or processing licensees;

(5)

Radioactive waste disposal licensees;

(6)

Source material milling licensees;

(7)

Ore refineries; and

(8)

Other persons with, or applicants for, a specific license as determined by the

Department.

3.9.5.4 Acceptable Financial Assurance Methods.

(1)

Financial assurance warranties shall contain provisions which are acceptable to

the Department for:

(a)

Defining the amount and term of the warranty;

(b)

Providing written notification to the Department by the warrantor at least

ninety (90) days prior to cancellation, termination, or revocation of the

warranty; and

(c)

Converting the warranty into cash upon forfeiture of the warranty, and

(2)

Financial assurance warranties shall be in the form of a cash deposit,

prepayment of a trust, escrow account, government fund, certificate of deposit, or

deposit of government securities.

(a)

Prepayment is the deposit prior to the start of operation into an account

segregated from licensee assets and outside the licensee’s

administrative control of cash or liquid assets such that the amount of

funds would be sufficient to pay decommissioning costs; or

(3)

Financial assurance warranties which involve a guarantee method to ensure that

costs will be paid should the licensee default shall be in a form as described

below:

(a)

A bond issued by a fidelity or surety company consistent with the

provisions of Section 25-11-110(6)(b)(l), CRS;

(b)

An irrevocable “letter of credit” or “line of credit” issued by a recognized

financial institution whose financial condition and commitment are

established to the satisfaction of the Department;

(c)

For a decommissioning warranty, a guarantee of funds by the applicant,

licensee, or parent company which satisfies the requirements listed

below. However, this self-guarantee shall not apply to uranium or thorium

milling licensees.

(i)

The Department may accept a parent company guarantee of

funds for decommissioning costs based upon a financial test of

the parent company and a written guarantee as contained in

Appendix 3F.

(ii)

The Department may accept an applicant or licensee guarantee

of funds for decommissioning costs based upon a financial test

of the applicant or licensee and a written guarantee as contained

in Appendix 3G.

(iii)

A guarantee by the applicant, licensee, or parent company may

not be used in combination with other financial methods to

satisfy the requirements of this section.

(iv)

A guarantee by the applicant or licensee may not be used in any

situation where the applicant or licensee has a parent company

holding majority control of the voting stock of the company; or

(4)

Financial assurance warranties which involve an external sinking fund shall be in

a form in which deposits are made at least annually, coupled with a surety

method or insurance, the value of which may decrease by the amount being

accumulated in the sinking fund.

(a)

An external sinking fund is a fund established and maintained by setting

aside funds periodically in an account segregated from licensee assets

and outside the licensee’s administrative control in which the total

amount of funds would be sufficient to pay decommissioning costs at the

time termination of operation is expected.

(b)

An external sinking fund may be in the form of a trust, escrow account,

government fund, certificate of deposit, or deposit of government

securities; or

(5)

Financial assurance warranties previously provided to any State, Federal and/or

local governing bodies concerning activities subject to license under these

regulations, where the amount, terms, and conditions of such financial assurance

warranties have been established to the satisfaction of the Department and in

accordance with the requirements of 3.9.5; or

(6)

Except for the guarantee of funds noted in 3.9.5.4(3), combinations of the above

may be used to establish an acceptable financial assurance warranty.

(7)

The term of the financial assurance warranty shall be open-ended or shall have

provisions for automatic renewal until termination of the license by the

Department, unless it can be demonstrated that another arrangement would

provide an equivalent level of assurance.

(8)

The value of the financial assurance warranty must not be dependent upon the

success, profitability, or continued operation of the licensed business or

operation.

3.9.5.5 The amount of funds to be provided by such decommissioning warranties shall be based

on Department-approved cost estimates and shall

(1)

Include the disposal of radioactive materials;

(2)

Include decontamination and decommissioning of buildings, facilities and the site

to levels which would allow unrestricted use of these areas upon

decommissioning;

(3)

Include the reclamation of tailings and/or waste disposal areas in accordance

with technical criteria delineated in Parts 3, 4 and/or 18, as appropriate;

(4)

Take into account total costs that would be incurred if an independent contractor

were hired to dispose of radioactive materials and perform decontamination,

decommissioning, and reclamation work, including:

(a)

The cost of removal and/or disposal of radioactive material, or a

radioactivity-inducing machine, which is or would be generated, stored,

processed or otherwise present at the facility or site; and

(b)

The probable extent of contamination through the possession or use of

radioactive material, at or adjacent to the facility or site, and the probable

cost of removal of such contamination; and

(5)

Include reasonable administrative costs, including indirect costs, incurred by the

Department in conducting or overseeing the decontamination, decommissioning,

and disposal activities, and to cover the Department's reasonable attorney costs

that may be incurred in successfully revoking, foreclosing, or realizing the

decommissioning warranties established by the licensee in accordance with Part

3.

3.9.5.6 The licensee shall provide in writing to the Department, no later than June 30th of each

calendar year, an annual report demonstrating proof of the value of existing financial

warranties and any licensee-proposed changes to the financial assurance warranties,

including updated decommissioning funding plans, cost estimates, or the type of

warranty. The annual report shall describe any changes in operations, estimated costs, or

any other circumstances that may affect the amount of the required financial assurance

warranties, including any increased or decreased costs attributable to inflation.

3.9.5.7 Each licensee's financial assurance warranties shall be subject to review annually by the

Department to assure the continued adequacy of each warranty. Public notice of the

submittal of the licensee's annual report shall be posted on the Department's web site

and published by the licensee in the local paper of general circulation. Any person may

submit written comments to the Department concerning the adequacy of any financial

assurance warranties. The act of submitting such comments does not provide a right to

administrative appeal concerning the financial assurance warranties.

3.9.5.8 The Department will determine if the licensee must adjust the amount of the warranty to

account for increases or decreases in cost estimates resulting from:

(1)

Inflation or deflation;

(2)

Changes in engineering plans;

(3)

Activities performed;

(4)

Spills, leakage or migration of radioactive material producing additional

contamination in onsite subsurface material that must be remediated to meet

applicable remediation criteria;

(5)

Waste inventory increasing above the amount previously estimated;

(6)

Waste disposal costs increasing above the amount previously estimated;

(7)

Facility modifications;

(8)

Changes in authorized possession limits;

(9)

Actual remediation costs that exceed the previous cost estimate;

(10)

Onsite disposal; and

(11)

Changes in any other conditions affecting disposal, decontamination, and

decommissioning costs.

3.9.5.9 Regardless of whether reclamation (disposal, decontamination and decommissioning) is

phased through the life of the licensed operations or takes place at the end of operations,

an appropriate portion of surety liability must be retained until final compliance with the

reclamation plan is determined by the Department.

3.9.5.10

The appropriate portion of surety liability retained until final compliance with the

reclamation plan is determined will be at least sufficient at all times to cover the costs of

decommissioning and reclamation of the areas that are expected to be disturbed before

the next license renewal. The term of the surety mechanism must be open ended, unless

it can be demonstrated that another arrangement would provide an equivalent level of

assurance. This assurance would be provided with a surety instrument which is written

for a specified time (e.g., 5 years) and which must be automatically renewed unless the

surety notifies the beneficiary (the NRC or the Department) and the principal (the

licensee) with reasonable time (e.g., 90 days) before the renewal date of their intention

not to renew. In such a situation the surety requirement still exists and the licensee would

be required to submit an acceptable replacement surety within a brief time to allow at

least 60 days for the regulatory agency to collect.

3.9.5.11

Proof of forfeiture must not be necessary to collect the surety. In the event the

licensee can not provide an acceptable replacement surety within the required time, the

surety shall be automatically collected before its expiration. The surety instrument must

provide for collection of the full face amount immediately on demand without reduction for

any reason, except for trustee fees and expenses provided for in a trust agreement, and

that the surety will not refuse to make full payment. The conditions described previously

would have to be clearly stated on any surety instrument which is not open ended, and

must be agreed to by all parties. Financial surety arrangements generally acceptable to

the Department are:

(1)

Trust funds;

(2)

Surety bonds;

(3)

Irrevocable letters of credit; and

(4)

Combinations of the financial surety arrangements or other types of

arrangements as may be approved by the Department. If a trust is not used, then

a standby trust must be set up to receive funds in the event the NRC or

Department exercises its right to collect the surety. The surety arrangement and

the surety or trustee, as applicable, must be acceptable to the Department. Self

insurance, or any arrangement which essentially constitutes self insurance (e.g.,

a contract with a State or Federal agency), will not satisfy the surety requirement

because this provides no additional assurance other than that which already

exists through license requirements.

3.9.5.12

With the approval of the Department, a licensee may reduce the amount of a

decommissioning warranty as decommissioning activities are completed in accordance

with an approved decommissioning plan and/or to reflect current site conditions and

license authorizations.

3.9.5.13

The licensee shall have sixty days after the date of written notification by the

Department of a required adjustment to establish a warranty fulfilling all new

requirements unless granted an extension by the Department. If the licensee disputes the

amount of the required financial assurance warranties, the licensee may request a

hearing to be conducted in accordance with section 24-4-105, CRS.

3.9.5.14

If the licensee requests a hearing, no new material ore or other radioactive

material may be brought on site for processing or disposal and no new radioactive

material may be processed until the licensee's dispute over the financial assurance

warranty is resolved, unless the licensee posts a bond in a form approved by the

Department equal to the amount in dispute.

LONG-TERM CARE WARRANTY

3.9.5.15

In addition to the decommissioning warranty required by 3.9.5.2, the Department

may require any licensee to provide a long-term care warranty if the licensed facility will

remain a disposal site for radioactive materials subsequent to the termination of the

license, or the license will be terminated using criteria in 4.61.3 or 4.61.4.

(1)

Except as provided in 3.9.5.15(2), the following specific licensees are required to

provide long-term care warranties:

(a)

Radioactive waste disposal licensees;

(b)

Commercial radioactive waste handling and/or packaging licensees;

(c)

Source material milling licensees; and

(d)

Formerly U.S. Atomic Energy Commission or U.S. Nuclear Regulatory

Commission-licensed facilities;

(2)

A long-term care warranty is not required for a licensee identified in 3.9.5.15(1) if

the disposition of radioactive materials by the licensee is made in such a manner

as the Department determines does not require long-term monitoring and

maintenance of the site.

(3)

The long-term care warranty shall be in a form as described in 3.9.5.4.

(4)

The amount of funds to be provided by such long-term care warranties shall be

based on Department-approved cost estimates and must be enough that with an

assumed one percent annual real interest rate, the annual interest earnings will

be sufficient to cover the annual costs of site surveillance, including reasonable

administrative costs incurred, in perpetuity, subsequent to the termination of the

license.

(a)

For each source material mill licensee, the long-term care warranty must

have a minimum value equivalent to $250,000 in 1978 dollars.

(i)

The value of the long-term care warranty shall be adjusted

annually to recognize inflation.

(ii)

The inflation rate to be used for this adjustment is that indicated

by the change in the consumer price index published by the U.S.

Department of Labor, Bureau of Labor Statistics.

(iii)

The Department may use other indicators of the inflation rate if

reasonable; provided, however, that the license shall not

terminate unless the amount of the long-term care warranty is

acceptable to the licensing agency and site caretaker.

(b)

Cost estimates for facilities and sites requiring long-term care

subsequent to license termination are to be based on the final disposition

of wastes such that ongoing active maintenance is not necessary to

preserve isolation.

(i)

It is expected that, as a minimum, annual site inspections shall

be conducted to confirm the integrity of the stabilized waste

systems and to determine the need, if any, for maintenance

and/or monitoring.

(ii)

Cost estimates shall be adjusted if more frequent site inspections

are required based on an evaluation of a particular site.

(c)

For sites decommissioned in accordance with the provisions of 4.61.3 or

4.61.4, cost estimates for long-term care subsequent to license

termination must be sufficient to enable the Department, a responsible

government agency, or an independent third party to:

(i)

Perform periodic site inspections no less frequently than each

five years;

(ii)

Assure the continuation of institutional controls; and

(iii)

Assume responsibilities and carry out any necessary control and

maintenance of the site. Cost estimates shall be adjusted if more

frequent site inspections are required based on an evaluation of

a particular site and the institutional controls established for that

site.

(5)

Whenever the Department determines that a licensee's disposal,

decommissioning and decontamination requirements have been satisfied,

provisions shall be made for transferring custody of the site and the long-term

care warranty funds for that license in accordance with the act.

(a)

If the value of the long-term care warranty funds exceeds the amount

required by the government agency overseeing the long-term care of the

site, then all such excess amounts shall be returned to the licensee.

3.9.6

Decommissioning Funding Plan Required.

3.9.6.1 Each applicant for and holder of a license authorizing the possession and use unsealed

radioactive materials with half-life greater than 120 days and in quantities greater than

105 times the applicable quantity of Schedule 3B, shall establish a Department-approved

decommissioning funding plan to assure the availability of funds for decommissioning

activities conducted over the life of the licensed facility. 370 Bq (0.01 µCi) shall be used

as the Schedule 3B value for any alpha emitting radionuclide not listed in Schedule 3B, or

mixtures of alpha emitters of unknown composition. A decommissioning funding plan is

also required for licensees authorized a combination of isotopes if R divided by 105 is

greater than 1 (unity rule), where R is defined in 3.9.5.3(2)(a).

3.9.6.2 Each holder of, or applicant for, any specific license authorizing the possession and use

of sealed sources or plated foils of half-life greater than 120 days and in quantities

greater than 1012 times the applicable quantity in Schedule 3B shall establish a

Department-approved decommissioning funding plan to assure the availability of funds

for decommissioning activities conducted over the life of the licensed facility. 370 Bq

(0.01 µCi) shall be used as the Schedule 3B value for any alpha emitting radionuclide not

listed in Schedule 3B, or mixtures of alpha emitters of unknown composition. The

decommissioning funding plan is also required for licensees authorized for a combination

of isotopes if R divided by 1012 is greater than 1 (unity rule), where R is defined as in

3.9.5.3(2)(a).

3.9.6.3 Waste collectors and waste processors, as defined in Part 4, Appendix D, shall establish

a Department-approved decommissioning funding plan to assure the availability of funds

for decommissioning activities conducted over the life of the licensed facility.

(1)

The decommissioning funding plan must include the cost of disposal of the

maximum radioactivity (becquerel or curie) of radioactive material permitted by

the license, and the cost of disposal of the maximum quantity, by volume, of

radioactive material that could be present at the licensee’s facility at any time, in

addition to the cost to remediate the licensee’s site to meet the license

termination criteria of Part 4.

3.9.6.4 Each decommissioning funding plan must be submitted for review and approval by the

Department and must contain:

(1)

A detailed cost estimate for decommissioning, in an amount reflecting:

(a)

The cost of an independent contractor to perform all decommissioning

activities;

(b)

The cost of meeting the 4.61.2 criteria for unrestricted use, provided that,

if the applicant or licensee can demonstrate its ability to meet the

provisions of 4.61.3 for restricted use, the cost estimate may be based

on meeting the 4.61.3 restricted use criteria;

(c)

The volume of onsite subsurface material containing residual

radioactivity that will require remediation to meet the criteria for license

termination; and

(d)

An adequate contingency factor.

(i)

Identification of and justification for using the key assumptions

contained in the detailed cost estimate;

(ii)

A description of the method of assuring funds for

decommissioning as required in this section, including means for

adjusting cost estimates and associated funding levels

periodically over the life of the facility.

(iii)

A certification by the licensee that financial assurance for

decommissioning has been provided in the amount of the cost

estimate for decommissioning; and

(iv)

A signed original, or if permitted, a copy, of the financial

instrument obtained to satisfy the requirements of this section

(unless a previously submitted and accepted financial instrument

continues to cover the cost estimate for decommissioning).

3.9.6.5 At the time of license renewal and at intervals not to exceed three years, the

decommissioning funding plan must be resubmitted with adjustments as necessary to

account for changes in costs and the extent of contamination. If the amount of financial

assurance will be adjusted downward, this can not be done until the updated

decommissioning funding plan is approved. The decommissioning funding plan must

update the information submitted with the original or prior approved plan, and must

specifically consider the effect of the following events on decommissioning costs:

(1)

Spills of radioactive material producing additional residual radioactivity in onsite

subsurface material;

(2)

Waste inventory increasing above the amount previously estimated;

(3)

Waste disposal costs increasing above the amount previously estimated;

(4)

Facility modifications;

(5)

Changes in authorized possession limits;

(6)

Actual remediation costs that exceed the previous cost estimate;

(7)

Onsite disposal; and

(8)

Use of a settling pond.

3.9.6.6 The decommissioning funding plan must also include a certification by the licensee that

funding for decommissioning activities has been provided for in the amount of the cost

estimate for decommissioning.

(1)

For an applicant, this certification may state that the appropriate assurance will

be obtained after the application has been approved and the license issued, but

prior to the receipt or possession of radioactive material.

(2)

A signed original of the financial instrument shall be submitted to the Department.

3.9.7

In the case of an application for a license for (1) source material milling, (2) commercial waste

storage, treatment or disposal by incineration, (3) transfer for disposal of waste from incineration,

(4) commercial waste disposal by land burial or by underground injection, or for (5) the conduct of

any other activity which the Department determines will significantly affect the quality of the

human environment, the Department, before commencement of construction, on the basis of

information filed and evaluations made, has concluded, after weighing the environmental,

economic, technical and other benefits against environmental costs and considering available

alternatives, that the action called for is the issuance of the proposed license with any appropriate

conditions to protect environmental values.

3.9.7.1 Commencement of construction prior to this conclusion is grounds for denial of a license

to possess and use source and byproduct material in the plant or facility.

3.9.8

Commencement of construction prior to the issuance of a license, or of an amendment or renewal

thereof, or of an exemption under the requirements of 3.8.7, may be grounds for denial of such

license, amendment or renewal.

3.9.9

Reserved.

3.9.10 License Hearings.

3.9.10.1

There shall be an opportunity for public hearings to be held in the following

circumstances in accordance with the procedures in 24-4-104 and -105, CRS. and this

paragraph:

(1)

Prior to the licensing or leasing of state-owned property for the concentration,

storage or permanent disposal of radioactive materials.

(2)

For each proposed license, five-year license renewal, or license amendment

pertaining to a uranium recovery facility's receipt of material as specified in Part

18 of these regulations.

3.9.11 Contingency Plans

3.9.11.1

Each application to possess radioactive materials in unsealed form, on foils or

plated sources, or sealed in glass in excess of the quantities in Schedule 3E - “Quantities

of Radioactive Materials Requiring Consideration of the Need for an Emergency Plan for

Responding to a Release”, must contain either:

(1)

An evaluation, as described in 3.9.11.2, showing that the projected dose to a

person offsite due to a release of radioactive materials would not exceed 0.01 Sv

(1 rem) effective dose equivalent or 0.05 Sv (5 rem) to the thyroid; or

(2)

A contingency plan for responding to a release of radioactive material.

3.9.11.2

In evaluating the total effective dose equivalent to an individual pursuant to

3.9.11.1(1):

(1)

The radioactive material is physically separated so that only a portion could be

involved in an accident;

(2)

All or part of the radioactive material is not subject to release during an accident

because of the way it is stored or packaged;

(3)

The release fraction in the respirable size range is predicted to be lower than the

release fraction shown in Schedule 3E due to the chemical or physical form of

the material;

(4)

The solubility of the radioactive material would reduce the dose received;

(5)

Facility design or engineered safety features in the facility would cause the

release fraction to be lower than shown in Schedule 3E.

(6)

Operating restrictions or procedures would prevent a release fraction as large as

that shown in Schedule 3E.

3.9.11.3

A contingency plan for responding to a release of radioactive material submitted

under 3.9.11.1(2) must include the following information, in separate sections having

each page numbered and labeled with a revision date and revision number:

(1)

Facility description - a brief description of the licensee's facility and surroundings.

(2)

Types of accidents - a n identification of each type of accident involving

radioactive material for which actions by licensee staff or offsite response

organizations will be needed to protect members of the public.

(3)

Classification of accidents - a method for classifying and declaring each alert or

site area emergency, as defined in Part 1.

(4)

Detection of accidents - identification of the means of detecting each type of

accident in a timely manner.

(5)

Mitigation of consequences - a brief description of the means and equipment for

mitigating the consequences of each type of accident, including those provided to

protect workers onsite, and a description of the program for maintaining the

equipment.

(6)

Assessment of releases - a brief description of the methods and equipment to

assess releases of radioactive materials.

(7)

Responsibilities - a brief description of the responsibilities of licensee personnel

should an accident occur, including identification of personnel responsible for

promptly notifying offsite response organizations and the Department; also

responsibilities for developing, maintaining, and updating the plan.

(8)

Notification and coordination.

(a)

A commitment to and a brief description of the means to promptly notify

offsite response organizations and request offsite assistance, including

medical assistance for the treatment of contaminated injured onsite

workers when appropriate.

(b)

A control point must be established.

(c)

The notification and coordination must be planned so that unavailability

of some personnel, parts of the facility, and some equipment will not

prevent the notification and coordination.

(d)

The licensee shall also commit to notify the Department immediately

after notification of the appropriate offsite response organizations and not

later than one hour after the licensee declares an emergency.

(9)

Information to be communicated - a brief description of the types of information

on facility status, radioactive releases, and recommended protective actions, if

necessary, to be given to offsite response organizations and to the Department.

(10)

Training.

(a)

A brief description of the frequency, performance objectives and plans

for the training that the licensee will provide workers on how to respond

to an emergency including any special instructions and orientation tours

the licensee would offer to fire, police, medical and other emergency

personnel.

(b)

The training shall familiarize personnel with site-specific emergency

procedures.

(c)

Also, the training shall thoroughly prepare site personnel for their

responsibilities in the event of accident scenarios postulated as most

probable for the specific site, including the use of team training for such

scenarios.

(11)

Safe shutdown - a brief description of the means of restoring the facility to a safe

condition after an accident.

(12)

Exercises.

(a)

Provisions for conducting quarterly communications checks with offsite

response organizations and biennial onsite exercises to test response to

simulated emergencies.

(b)

Quarterly communications checks with offsite response organizations

must include the check and update of all necessary telephone numbers.

(c)

The licensee shall invite offsite response organizations to participate in

the biennial exercises.

(d)

Participation of offsite response organizations in biennial exercises

although recommended is not required.

(e)

Exercises must use accident scenarios postulated as most probable for

the specific site and the scenarios shall not be known to most exercise

participants.

(f)

The licensee shall critique each exercise using individuals not having

direct implementation responsibility for the plan.

(g)

Critiques of exercises must evaluate the appropriateness of the plan,

emergency procedures, facilities, equipment, training of personnel, and

overall effectiveness of the response.

(h)

Deficiencies found by the critiques must be corrected.

(13)

Hazardous chemicals - a certification that the applicant has met its

responsibilities under the Emergency Planning and Community Right-To-Know

Act of 1986, Title III, Pub. L. 99-499, if applicable to the applicant's activities at

the proposed place of use of the radioactive material.

3.9.11.4

The licensee shall allow the offsite response organizations expected to respond

in case of an accident 60 days to comment on the licensee's emergency plan before

submitting it to the Department.

(1)

The licensee shall provide any comments received within 60 days to the

Department with the emergency plan.

3.10

Additional Requirements for Issuance of Specific Licenses for Use of Unsealed

Radioactive Material.

3.10.1 In addition to the requirements set forth in 3.9, applicants for licenses authorizing the possession

and use of unsealed radioactive materials shall include in the application a description of the

facility and procedures for operation which

3.10.1.1

Minimize to the extent practicable, contamination of the facility and environment;

3.10.1.2

Facilitate eventual decommissioning; and

3.10.1.3

Minimize, to the extent practicable, the generation of radioactive waste.

3.10.2 Licensees shall, to the extent practical, conduct operations to minimize the introduction of

residual radioactivity into the site, including the subsurface, in accordance with the existing

radiation protection requirements in Part 4, Section 4.5 and radiological criteria for license

termination in Part 4, Section 4.61 of the regulations.

3.11

Special Requirements for Specific Licenses of Broad Scope.

3.11.1 This section prescribes requirements for the issuance of specific licenses of broad scope for

radioactive material and certain regulations governing holders of the types of broad licenses set

forth below.7

7 Authority to transfer possession or control by the manufacturer, processor, or producer of any equipment, device, commodity, or

other product containing byproduct material whose subsequent possession, use, transfer, and disposal by all other persons are

exempted from regulatory requirements may be obtained only from the U.S. Nuclear Regulatory Commission, Washington, D.C.

20555.

3.11.1.1

A “Type A specific license of broad scope” is a specific license authorizing

receipt, acquisition, ownership, possession, use and transfer of any chemical or physical

form of the radioactive material specified in the license, but not exceeding quantities

specified in the license, for any authorized purpose.

(1)

The quantities specified are usually in the multicurie range.

3.11.1.2

A “Type B specific license of broad scope” is a specific license authorizing

receipt, acquisition, possession, use and transfer of any chemical or physical form of

radioactive material specified in Schedule 3D of this part, for any authorized purpose.

(1)

The possession limit for a Type B license of broad scope, if only one radionuclide

is possessed thereunder, is the quantity specified for that radionuclide in

Schedule 3D, Column I.

(2)

If two or more radionuclides are possessed thereunder, the possession limit for

each is determined as follows: For each radionuclide, determine the ratio of the

quantity possessed to the applicable quantity specified in Schedule 3D, Column

I, for that radionuclide.

(3)

The sum of the ratios for all radionuclides possessed under the license shall not

exceed unity.

3.11.1.3

A “Type C specific license of broad scope” is a specific license authorizing

receipt, acquisition, ownership, possession, use, and transfer of any chemical or physical

form of radioactive material specified in Schedule 3D of this part, for any authorized

purpose.

(1)

The possession limit for a Type C license of broad scope, if only one radionuclide

is possessed thereunder, is the quantity specified for that radionuclide in

Schedule 3D, Column II.

(2)

If two or more radionuclides are possessed thereunder, the possession limit is

determined for each as follows: For each radionuclide, determine the ratio of the

quantity possessed to the applicable quantity specified in Schedule 3D, Column

II, for that radionuclide.

(3)

The sum of the ratios for all radionuclides possessed under the license shall not

exceed unity.

3.11.2 An application for a Type A specific license of broad scope will be approved if:

3.11.2.1

The applicant satisfies the general requirements specified in 3.9;

3.11.2.2

The applicant has engaged in a reasonable number of activities involving the use

of radioactive material; and

3.11.2.3

The applicant has established administrative controls and provisions relating to

organization and management, procedures, record keeping, material control and

accounting, and management review that are necessary to assure safe operations,

including:

(1)

The establishment of a radiation safety committee composed of such persons as

a radiation safety officer, a representative of management, and persons trained

and experienced in the safe use of radioactive material;

(2)

The appointment of a radiation safety officer who is qualified by training and

experience in radiation protection, and who is available for advice and assistance

on radiation safety matters; and

(3)

The establishment of appropriate administrative procedures to assure:

(a)

Control of procurement and use of radioactive material;

(b)

Completion of safety evaluations of proposed uses of radioactive

material which take into consideration such matters as the adequacy of

facilities and equipment, training and experience of the user, the

operating or handling procedures; and

(c)

Review, approval, and recording by the radiation safety committee of

safety evaluations of proposed uses prepared in accordance with

3.11.2.3(3)(b) prior to use of the radioactive material.

3.11.3 An application for a Type B specific license of broad scope will be approved if:

3.11.3.1

The applicant satisfies the general requirements specified in 3.9; and

3.11.3.2

The applicant has established administrative controls and provisions relating to

organization and management, procedures, record keeping, material control and

accounting, and management review that are necessary to assure safe operations,

including:

(1)

The appointment of a radiation safety officer who is qualified by training and

experience in radiation protection, and who is available for advice and assistance

on radiation safety matters; and

(2)

The establishment of appropriate administrative procedures to assure;

(a)

Control of procurement and use of radioactive material;

(b)

Completion of safety evaluations of proposed uses of radioactive

material which take into consideration such matters as the adequacy of

facilities and equipment, training and experience of the user, and the

operating or handling procedures; and

(c)

Review, approval, and recording by the radiation safety officer of safety

evaluations of proposed uses prepared in accordance with 3.11.3.2(2)(b)

prior to use of the radioactive material.

3.11.4 An application for a Type C specific license of broad scope will be approved if:

3.11.4.1

The applicant satisfies the general requirements specified in 3.9;

3.11.4.2

The applicant submits a statement that radioactive material will be used only by,

or under the direct supervision of, individuals who have received:

(1)

A college degree at the bachelor level, or equivalent training and experience, in

the physical or biological sciences or in engineering, and

(2)

At least 40 hours of training and experience in the safe handling of radioactive

material, and in the characteristics of ionizing radiation, units of radiation dose

and quantities, radiation detection instrumentation, and biological hazards of

exposure to radiation appropriate to the type and forms of radioactive material to

be used; and

3.11.4.3

The applicant has established administrative controls and provisions relating to

procurement of radioactive material, procedures, record keeping, material control and

accounting, and management review necessary to assure safe operations.

3.11.5 Specific licenses of broad scope are subject to the following conditions:

3.11.5.1

Unless specifically authorized, persons licensed pursuant to 3.11 shall not:

(1)

Conduct tracer studies in the environment involving direct release of radioactive

material;

(2)

Receive, acquire, own, possess, use; or transfer devices containing 3.7 PBq (100

kCi) or more of radioactive material in sealed sources used for irradiation of

materials;

(3)

Conduct activities for which a specific license issued by the Department under

Part 3, 5, or 7 is required; or

(4)

Add or cause the addition of radioactive material to any food, beverage,

cosmetic, drug, or other product designed for ingestion or inhalation by, or

application to, a human being.

3.11.5.2

Each Type A specific license of broad scope issued under this part shall be

subject to the condition that radioactive material possessed under the license may only

be used by, or under the direct supervision of, individuals approved by the licensee's

radiation safety committee.

3.11.5.3

Each Type B specific license of broad scope issued under this part shall be

subject to the condition that radioactive material possessed under the license may only

be used by, or under the direct supervision of, individuals approved by the licensee's

radiation safety officer.

3.11.5.4

Each Type C specific license of broad scope issued under this part shall be

subject to the condition that radioactive material possessed under the license may only

be used by, or under the direct supervision of, individuals who satisfy the requirements of

3.11.4.

3.12

Special Requirements for a Specific License to Manufacture, Assemble, Repair, or

Distribute Commodities, Products, or Devices which Contain Radioactive Material.

3.12.1 A licensee authorized to introduce radioactive material into a product or material owned by or in

the possession of the licensee or another to be transferred to persons exempt under 3.3.1.1 shall

meet the requirements of 10 CFR Part 32.11 and any other applicable NRC requirement.

3.12.2 No person may introduce byproduct material into a product or material knowing or having reason

to believe that it will be transferred to persons exempted pursuant to 3.3.2, under 10 CFR Part

30.14 or equivalent regulations of an Agreement State, except in accordance with a license

issued under 10 CFR Part 32.8

8 Authority to transfer possession or control by the manufacturer, processor, or producer of any equipment, device, commodity, or

other product containing byproduct material whose subsequent possession, use, transfer, and disposal by all other persons are

exempted from regulatory requirements may be obtained only from the U.S. Nuclear Regulatory Commission, Washington, D.C.

20555.

3.12.2.3

Each person licensed under 3.12.2 shall maintain records identifying, by name

and address, each person to whom radioactive material is transferred for use under

3.3.2, and stating the kinds and quantities of radioactive material transferred. An annual

summary report stating the total quantity of each radionuclide transferred under the

specific license shall be filed with the Department. Each report shall cover the year

ending June 30, and shall be filed within 30 days thereafter. If no transfers of radioactive

material have been made pursuant to 3.12.2 during the reporting period, the report shall

so indicate.

3.12.3 RESERVED.

3.12.4 Licensing the Manufacture and Distribution of Devices to Persons Generally Licensed Under

3.6.4.

3.12.4.1

An application for a specific license to manufacture, or initially transfer devices

containing radioactive material, excluding special nuclear material, to persons generally

licensed under 3.6.4 or equivalent regulations of NRC or an Agreement State will be

approved if:

(1)

The applicant satisfies the general requirements of 3.9;

(2)

The applicant submits sufficient information relating to the design, manufacture,

prototype testing, quality control, labels, proposed uses, installation, servicing,

leak testing, operating and safety instructions, and potential hazards of the

device to provide reasonable assurance that:

(a)

The device can be safely operated by persons not having training in

radiological protection;

(b)

Under ordinary conditions of handling, storage, and use of the device,

the radioactive material contained in the device will not be released or

inadvertently removed from the device, and it is unlikely that any person

will receive in any period of 1 calendar quarter a dose in excess of 10

percent of the limits specified in 4.6.1; and

(c)

Under accident conditions such as fire and explosion associated with

handling, storage, and use of the device, it is unlikely that any person

would receive an external radiation dose or dose commitment in excess

of the following organ doses:

(i)

Whole body; head and trunk; active blood-forming organs;

gonads; or lens of eye: 150 mSv (15 rem)

(ii)

Hands and forearms; feet and ankles; localized areas of skin

averaged over areas no larger than 1 square centimeter: 2 Sv

(200 rem)

(iii)

Other organs: 500 mSv (50 rem); and

(3)

Each device bears a durable, legible, clearly visible label or labels approved by

the Department, which contain in a clearly identified and separate statement:

(a)

Instructions and precautions necessary to assure safe installation,

operation, and servicing of the device; documents such as operating and

service manuals may be identified in the label and used to provide this

information;

(b)

The requirement, or lack of requirement, for leak testing, or for testing

any “on-off” mechanism and indicator, including the maximum time

interval for such testing, and the identification of radioactive material by

isotope, quantity of radioactivity, and date of determination of the

quantity; and

(c)

The information called for in one of the following statements, as

appropriate, in the same or substantially similar form:

(i)

The receipt, possession, use, and transfer of this device, Model

___, Serial No. ___9, are subject to a general license or the

equivalent and the regulations of the U.S. Nuclear Regulatory

Commission or an Agreement State. This label shall be

maintained on the device in a legible condition. Removal of this

label is prohibited.

CAUTION - RADIOACTIVE MATERIAL

________________________________

Name of manufacturer or distributor

9 The model, serial number, and name of the manufacturer or distributor may be omitted from this label provided the information is

elsewhere specified in labeling affixed to the device.

(ii)

The receipt, possession, use, and transfer of this device,

Model___, Serial No. ___10, are subject to a general license or

the equivalent, and the radiation regulations. This label shall be

maintained on the device in a legible condition. Removal of this

label is prohibited.

CAUTION - RADIOACTIVE MATERIAL

________________________________

Name of manufacturer or distributor

10 The model, serial number, and name of the manufacturer or distributor may be omitted from this label provided the information is

elsewhere specified in labeling affixed to the device.

(4)

Each device having a separable source housing that provides the primary

shielding for the source also bears, on the source housing, a durable label

containing the device model number and serial number, the isotope and quantity,

the words, “Caution-Radioactive Material,” the radiation symbol prescribed in

4.27 and the name of the manufacturer or initial distributor.

(5)

The device has been registered in the Sealed Source and Device Registry.

3.12.4.2

In the event the applicant desires that the device be required to be tested at

intervals longer than 6 months, either for proper operation of the “on-off” mechanism and

indicator, if any, or for leakage of radioactive material or for both, the applicant shall

include in the application sufficient information to demonstrate that such longer interval is

justified by performance characteristics of the device or similar devices and by design

features which have a significant bearing on the probability or consequences of leakage

of radioactive material from the device or failure of the “on-off” mechanism and indicator.

3.12.4.3

In determining the acceptable interval for the test for leakage of radioactive

material, the Department will consider information which includes, but is not limited to:

(1)

Primary containment or source capsule;

(2)

Protection of primary containment;

(3)

Method of sealing containment;

(4)

Containment construction materials;

(5)

Form of contained radioactive material;

(6)

Maximum temperature withstood during prototype tests;

(7)

Maximum pressure withstood during prototype tests;

(8)

Maximum quantity of contained radioactive material;

(9)

Radiotoxicity of contained radioactive material; and

(10)

Operating experience with identical devices or similarly designed and

constructed devices.

3.12.4.4

In the event the applicant desires that the general licensee under 3.6.4, or under

equivalent regulations of NRC or an Agreement State, be authorized to install the device,

collect the sample to be analyzed by a specific licensee for leakage of radioactive

material, service the device, test the “on-off” mechanism and indicator, or remove the

device from installation, the applicant shall include in the application written instructions

to be followed by the general licensee, estimated calendar quarter doses associated with

such activity or activities, and bases for such estimates.

(1)

The submitted information shall demonstrate that performance of such activity or

activities by an individual untrained in radiological protection, in addition to other

handling, storage, and use of devices under the general license, is unlikely to

cause that individual to receive a calendar quarter dose in excess of 10 percent

of the limits specified in 4.6.1.

3.12.4.5

Each person licensed under 3.12.4 to distribute devices to generally licensed

person shall:

(1)

Before a device is transferred, furnish information specified in this paragraph to

each person to whom a device is to be transferred, or in the case of a transfer

through an intermediate person, to the intended user prior to initial transfer to the

intermediate person, including:

(a)

A copy of the general license contained in 3.6.4 and a copy of the

general license contained in the NRC or Agreement State regulation

equivalent to 3.6.4;

(b)

A copy of sections 3.6 and 4.40 through 4.52;

(c)

A list of the services that can only be performed by a specific licensee;

(d)

Information on acceptable disposal options including estimated costs of

disposal;

(e)

An indication that federal policy is to issue high civil penalties for

improper disposal; and

(f)

The name or title, address, and phone number of the contact at the

transferee’s NRC or Agreement State location.

(2)

Report to the Department all transfers of such devices to persons for use under

the general license in 3.6.4 and all receipts of such devices.

(a)

Such a report to the Department shall include:

(i)

The identity of each general licensee by name and mailing

address for the location of use; if there is no mailing address for

the location of use, an alternate address for the general licensee

shall be submitted along with information on the actual location

of use;

(ii)

The name, title, and phone number of the person identified by

the general licensee as having knowledge of and authority to

take required actions to ensure compliance with the appropriate

regulations and requirements;

(iii)

The date of transfer;

(iv)

The type, model number, and serial number of the device

transferred; and

(v)

The quantity and type of radioactive material contained in the

device.

(b)

If one or more intermediate persons will temporarily possess the device

at the intended place of use before its possession by the user, the report

must include the same information for both the intended user and each

intermediate person, and clearly designate the intermediate person(s).

(c)

For devices received from a 3.6.4 general licensee, the report must

include the identity of the general licensee by name and address, the

type, model number, and serial number of the device received, the date

of receipt, and, in the case of devices not initially transferred by the

reporting licensee, the name of the manufacturer or initial transferor.

(d)

If the licensee makes changes to a device possessed by a 3.6.4 general

licensee, such that the label must be changed to update required

information, the report must identify the general licensee, the device, and

the changes to information on the device label.

(e)

The report must cover each calendar quarter, must be filed within 30

days of the end of the calendar quarter, and must clearly indicate the

period covered by the report.

(f)

The report must clearly identify the specific licensee submitting the report

and include the license number of the specific licensee.

(g)

If no transfers have been made to or from persons generally licensed

under 3.6.4 during the reporting period, the report must so indicate.

(3)

Furnish clear and legible reports to other agencies, containing all of the data

required by Form 653, “Transfers of Industrial Devices Report”, including:

(a)

Report the information specified in 3.12.4.5(2) to NRC for all transfers of

such devices to persons for use under NRC general license in Section

31.5 of 10 CFR Part 31.

(b)

Report the information specified in 3.12.4.5 (2) to the responsible State

agency for all transfers of devices manufactured and distributed pursuant

to 3.12.4 for use under a general license in that State's regulations

equivalent to 3.6.4.

(4)

Maintain all information concerning transfers and receipts of devices that

supports the reports required by this section for a period of 3 years following the

date of the recorded event.

3.12.5 Special Requirements for the Manufacture, Assembly, Repair or Initial Transfer of Luminous

Safety Devices for Use in Aircraft.

3.12.5.1

An application for a specific license to manufacture, assemble, repair or initially

transfer luminous safety devices containing tritium or promethium-147 for use in aircraft,

for distribution to persons generally licensed under 3.6.5 will be approved if:

(1)

The applicant satisfies the general requirements specified in 3.9; and

(2)

The applicant satisfies the requirements of Sections 32.53, 32.54, 32.55, and

32.56 of 10 CFR Part 32, or their equivalent.

(3)

The device has been registered in the Sealed Source and Device Registry.

3.12.6 Special Requirements for License to Manufacture or initially transfer Calibration Sources

Containing Americium–241, Plutonium or Radium-226 for Distribution to Persons Generally

Licensed Under 3.6.7.

3.12.6.1

An application for a specific license to manufacture calibration and reference

sources containing americium-241, plutonium or radium-226 to persons generally

licensed under 3.6.7 will be approved if:

(1)

The applicant satisfies the general requirement of 3.9; and

(2)

The applicant satisfies the requirements of Sections 32.57, 32.58, and 32.59 of

10 CFR Part 32 and Section 70.39 of 10 CFR Part 70 or their equivalent.

3.12.7 Reserved.

3.12.8 Manufacture and Distribution of Radioactive Material for Certain In Vitro Clinical or Laboratory

Testing Under General License.

3.12.8.1

An application for a specific license to manufacture or distribute radioactive

material for use under the general license of 3.6.9 will be approved if:

(1)

The applicant satisfies the general requirements specified in 3.9.

(2)

The radioactive material is to be prepared for distribution in prepackaged units of:

(a)

Carbon-14 in units not exceeding 370 kBq (10 µCi) each.

(b)

Cobalt-57 in units not exceeding 370 kBq (10 µCi) each.

(c)

Hydrogen-3 (tritium) in units not exceeding 1.85 MBq (50 µCi) each.

(d)

Iodine-125 in units not exceeding 370 kBq (10 µCi) each.

(e)

Mock Iodine-125 in units not exceeding 1.85 kBq (0.05 µCi) of iodine-129

and 185 kBq (0.005 µCi) of americium-241 each.

(f)

Iodine-131 in units not exceeding 370 kBq (10 µCi) each.

(g)

Iron-59 in units not exceeding 740 kBq (20 µCi) each.

(h)

Selenium-75 in units not exceeding 370 kBq (10 µCi) each.

(3)

Each prepackaged unit bears a durable, clearly visible label:

(a)

Identifying the radioactive contents as to chemical form and radionuclide,

and indicating that the amount of radioactivity does not exceed 370 kBq

(10 µCi) of iodine-125, iodine-131, carbon-14, cobalt-57, or selenium-75;

1.85 MBq (50 µCi) of hydrogen-3 (tritium); 740 kBq (20 µCi) of iron-59; or

Mock Iodine-125 in units not exceeding 1.85 kBq (0.05 µCi) of iodine-129

and 185 Bq (0.005 µCi) of americium-241 each; and

(b)

Displaying the radiation caution symbol described in 4.27.1and the

words, “CAUTION, RADIOACTIVE MATERIAL”, and “Not for Internal or

External Use in Humans or Animals”.

(4)

One of the following statements, as appropriate, or a substantially similar

statement which contains the information called for in one of the following

statements, appears on a label affixed to each prepackaged unit or appears in a

leaflet or brochure which accompanies the package:

(a)

This radioactive material may be received, acquired, possessed, and

used only by physicians, veterinarians, clinical laboratories or hospitals

and only for in vitro clinical or laboratory tests not involving internal or

external administration of the material, or the radiation therefrom, to

human beings or animals. Its receipt, acquisition, possession, use, and

transfer are subject to the regulations and a general license of NRC or

an Agreement State.

___________________________________

Name of manufacturer

(5)

The label affixed to the unit, or the leaflet or brochure which accompanies the

package, contains adequate information as to the precautions to be observed in

handling and storing such radioactive material. In the case of the Mock Iodine-

125 reference or calibration source, the information accompanying the source

must also contain directions to the licensee regarding the waste disposal

requirements set out in 4.33.

3.12.9 Licensing the Manufacture or initial transfer of Ice Detection Devices.

3.12.9.1

An application for a specific license to manufacture and distribute ice detection

devices to persons generally licensed under 3.6.10 will be approved if:

(1)

The applicant satisfies the general requirements of 3.9; and

(2)

The criteria of Sections 32.61, and 32.62 of 10 CFR Part 32 are met.

(3)

The device has been registered in the Sealed Source and Device Registry.

3.12.10 Manufacture, Preparation, or Transfer for Commercial Distribution of Radioactive Drugs for

Medical Use.

3.12.10.1

An application for a specific license to manufacture, prepare, or transfer for

commercial distribution radioactive drugs containing radioactive material for use by

persons authorized under Part 7 will be approved if:

(1)

The applicant satisfies the general requirements specified in 3.9;

(2)

The applicant submits evidence that the applicant is at least one of the following:

(a)

Registered or licensed with the U.S. Food and Drug Administration

(FDA) as the owner or operator of a drug establishment that engages in

the manufacture, preparation, propagation, compounding, or processing

of a drug under 21 CFR Part 207.17(a);

(b)

Registered or licensed with the State Board of Pharmacy as a drug

manufacturer;

(c)

Licensed as a pharmacy by the State Board of Pharmacy;

(d)

Operating as a nuclear pharmacy within a Federal medical institution; or

(e)

A Positron Emission Tomography (PET) drug production facility

registered with the State Board of Pharmacy.

(3)

The applicant submits information on the radionuclide; the chemical and physical

form; the maximum activity per vial, syringe, generator, or other container of the

radioactive drug; and the shielding provided by the packaging to show it is

appropriate for safe handling and storage of the radioactive drugs by medical use

licensees; and

(4)

The applicant has procedures which commit to the following labeling

requirements:

(a)

A label is affixed to each transport radiation shield, whether it is

constructed of lead, glass, plastic, or other material of a radioactive drug

to be transferred for commercial distribution.

(i)

The label must include the radiation symbol prescribed in 4.27

and the words “CAUTION, RADIOACTIVE MATERIAL” or

“DANGER, RADIOACTIVE MATERIAL”; the name of the

radioactive drug or its abbreviation; and the quantity of

radioactivity at a specified date and time.

(ii)

For radioactive drugs with a half-life greater than 100 days, the

time may be omitted.

(b)

A label is affixed to each syringe, vial, or other container used to hold a

radioactive drug to be transferred for commercial distribution. The label

must include:

(i)

The radiation symbol prescribed in 4.27 and the words

“CAUTION, RADIOACTIVE MATERIAL” or “DANGER,

RADIOACTIVE MATERIAL”; and

(ii)

An identifier that ensures that the syringe, vial or other container

can be correlated with the information on the transport radiation

shield label.

3.12.10.2

A licensee described by 3.12.10.1(2)(c) or 3.12.10.1(2)(d):

(1)

May prepare radioactive drugs for medical use, as defined in Part 1, Section 1.2

and Part 7, provided that the radioactive drug is prepared by either:

(a)

An authorized nuclear pharmacist, as specified in 3.12.10.2(2) or

3.12.10.2(4), or

(b)

An individual under the direct supervision of an authorized nuclear

pharmacist as specified in Part 7, Section 7.10;

(2)

May allow a pharmacist to work as an authorized nuclear pharmacist if:

(a)

This individual qualifies as an Authorized Nuclear Pharmacist as defined

in Part 7, Section 7.2;

(b)

This individual meets the requirements specified in Part 7 Appendix 7C2

and Section 7.65, and the licensee has received an approved license

amendment identifying this individual as an authorized nuclear

pharmacist; or

(c)

This individual is designated as an authorized nuclear pharmacist in

accordance with 3.12.10.2(4).

(3)

The actions authorized in 3.12.10.2(1) and 3.12.10.2(2) are permitted in spite of

more restrictive language in license conditions.

(4)

May designate a pharmacist (as defined in Part 7, Section 7.2) as an authorized

nuclear pharmacist if:

(a)

The individual was a nuclear pharmacist preparing only radioactive drugs

containing accelerator-produced radioactive material, and

(b)

The individual practiced at a pharmacy at a Government agency or

Federally recognized Indian Tribe before November 30, 2007 or at all

other pharmacies before August 8, 2009, or an earlier date as noticed by

the NRC.

(5)

Shall provide to the Department:

(a)

A copy of each individual’s certification by a specialty board whose

certification process has been recognized by the NRC or an Agreement

State as specified in Part 7, Appendix 7C1; or

(b)

The Department, NRC or Agreement State license, or

(c)

NRC master materials licensee permit, or

(d)

The permit issued by a licensee or NRC master materials permittee of

broad scope or the authorization from a commercial nuclear pharmacy

authorized to list its own authorized nuclear pharmacist, or

(e)

Documentation that only accelerator-produced radioactive materials

were used in the practice of nuclear pharmacy at a Government agency

or Federally recognized Indian Tribe before November 30, 2007 or at all

other locations of use before August 8, 2009, or an earlier date as

noticed by the NRC; and

(f)

A copy of the State pharmacy licensure or registration, no later than 30

days after the date that the licensee allows, under 3.12.10.2(2)(a) and

3.12.10.2(2)(c), the individual to work as an authorized nuclear

pharmacist.

3.12.10.3

A licensee shall possess and use instrumentation to measure the radioactivity of

radioactive drugs.

(1)

The licensee shall have procedures for use of the instrumentation.

(2)

The licensee shall measure, by direct measurement or by combination of

measurements and calculations, the amount of radioactivity in dosages of alpha-,

beta- or photon-emitting radioactive drugs prior to transfer for commercial

distribution.

(3)

In addition, the licensee shall:

(a)

Perform tests before initial use, periodically, and following repair, on

each instrument for accuracy, linearity and geometry dependence, as

appropriate for the use of the instrument; and make adjustments when

necessary; and

(b)

Check each instrument for constancy and proper operation at the

beginning of each day of use.

3.12.10.4

A licensee shall satisfy the labeling requirements in 3.12.10.1(4).

3.12.10.5

Nothing in this section relieves the licensee from complying with applicable FDA,

Federal, and state requirements governing radioactive drugs.

3.12.11 Reserved.

3.12.12 Manufacture and Distribution of Sources or Devices Containing Radioactive Material for Medical

Use.

3.12.12.1

An application for a specific license to manufacture and distribute sources and

devices containing radioactive material to persons licensed pursuant to Part 7 for use as

a calibration, transmission, or reference source or for the uses listed in Part 7, Sections

7.19, 7.40, 7.42, 7.48 and 7.62 will be approved if:

(1)

The applicant satisfies the general requirements in 3.9 of this part;

(2)

The applicant submits sufficient information regarding each type of source or

device pertinent to an evaluation of its radiation safety, including:

(a)

The radioactive material contained, its chemical and physical form, and

amount,

(b)

Details of design and construction of the source or device,

(c)

Procedures for, and results of, prototype tests to demonstrate that the

source or device will maintain its integrity under stresses likely to be

encountered in normal use and accidents,

(d)

For devices containing radioactive material, the radiation profile of a

prototype device,

(e)

Details of quality control procedures to assure that production sources

and devices meet the standards of the design and prototype tests,

(f)

Procedures and standards for calibrating sources and devices,

(g)

Legend and methods for labeling sources and devices as to their

radioactive content, and

(h)

Instructions for handling and storing the source or device from the

radiation safety standpoint; these instructions are to be included on a

durable label attached to the source or device or attached to a

permanent storage container for the source or device; provided, that

instructions which are too lengthy for such label may be summarized on

the label and printed in detail on a brochure which is referenced on the

label;

(3)

The label affixed to the source or device, or to the permanent storage container

for the source or device, contains information on the radionuclide, quantity, and

date of assay, and a statement that the source or device is licensed by the

Department for distribution to persons licensed pursuant to Part 7, Sections 7.40

and 7.42 or under equivalent licenses of NRC or an Agreement State, provided

that such labeling for sources which do not require long term storage may be on

a leaflet or brochure which accompanies the source;

(4)

The source or device has been registered in the Sealed Source and Device

Registry.

3.12.12.2

In the event the applicant desires that the source or device be required to be

tested for leakage of radioactive material at intervals longer than 6 months, the applicant

shall include in the application sufficient information to demonstrate that such longer

interval is justified by performance characteristics of the source or device or similar

sources or devices and by design features that have a significant bearing on the

probability or consequences of leakage of radioactive material from the source; and

3.12.12.3

In determining the acceptable interval for test of leakage of radioactive material,

the Department will consider information that includes, but is not limited to:

(1)

Primary containment or source capsule,

(2)

Protection of primary containment,

(3)

Method of sealing containment,

(4)

Containment construction materials,

(5)

Form of contained radioactive material,

(6)

Maximum temperature withstood during prototype tests,

(7)

Maximum pressure withstood during prototype tests,

(8)

Maximum quantity of contained radioactive material,

(9)

Radiotoxicity of contained radioactive material, and

(10)

Operating experience with identical sources or devices or similarly designed and

constructed sources or devices.

3.12.13 Requirements for License to Manufacture and Distribute Industrial Products Containing Depleted

Uranium for Mass-Volume Applications.

3.12.13.1

An application for a specific license to manufacture industrial products and

devices containing depleted uranium for use pursuant to 3.5.5 or equivalent regulations

of NRC or an Agreement State will be approved if:

(1)

The applicant satisfies the general requirements specified in 3.9;

(2)

The applicant submits sufficient information relating to the design, manufacture,

prototype testing, quality control procedures, labeling or marking, proposed uses,

and potential hazards of the industrial product or device to provide reasonable

assurance that possession, use, or transfer of the depleted uranium in the

product or device is not likely to cause any individual to receive in any period of 1

calendar quarter a radiation dose in excess of 10 percent of the limits specified in

4.6.1; and

(3)

The applicant submits sufficient information regarding the industrial product or

device and the presence of depleted uranium for a mass-volume application in

the product or device to provide reasonable assurance that unique benefits will

accrue to the public because of the usefulness of the product or device.

3.12.13.2

In the case of an industrial product or device whose unique benefits are

questionable, the Department will approve an application for a specific license under

3.12.13 only if the product or device is found to combine a high degree of utility and low

probability of uncontrolled disposal and dispersal of significant quantities of depleted

uranium into the environment.

3.12.13.3

The Department may deny any application for a specific license under 3.12.13 if

the end use(s) of the industrial product or device cannot be reasonably foreseen.

3.12.13.4

Each person licensed pursuant to 3.12.13.1 shall:

(1)

Maintain the level of quality control required by the license in the manufacture of

the industrial product or device, and in the installation of the depleted uranium

into the product or device;

(2)

Label or mark each unit to:

(a)

Identify the manufacturer of the product or device and the number of the

license under which the product or device was manufactured, the fact

that the product or device contains depleted uranium, and the quantity of

depleted uranium in each product or device; and

(b)

State that the receipt, possession, use, and transfer of the product or

device are subject to a general license or the equivalent and the

regulations of NRC or an Agreement State;

(3)

Assure that the depleted uranium before being installed in each product or device

has been impressed with the following legend clearly legible through any plating

or other covering: “Depleted Uranium”;

(4)

Furnish a copy of the general license:

(a)

Contained in 3.5.5 and a copy of Department Form R-52 to each person

to whom the specific licensee transfers depleted uranium in a product or

device for use pursuant to the general license contained in 3.5.5, or

(b)

Contained in an NRC or Agreement State regulation equivalent to 3.5.5

and a copy of an NRC or Agreement State certificate, or alternatively,

furnish a copy of the general license contained in 3.5.5 and a copy of

Department Form R-52 to each person to whom the specific licensee

transfers depleted uranium in a product or device for use pursuant to the

general license of NRC or an Agreement State, with a note explaining

that use of the product or device is regulated by NRC or an Agreement

State under requirements substantially the same as those in 3.5.5;

(5)

Report to the Department all transfers of industrial products or devices to

persons for use under the general license in 3.5.5.

(a)

Such report shall identify each general licensee by name and address,

an individual by name and/or position who may constitute a point of

contact between the Department and the general licensee, the type and

model number of device transferred, and the quantity of depleted

uranium contained in the product or device.

(b)

The report shall be submitted within 30 days after the end of each

calendar quarter in which such a product or device is transferred to the

generally licensed person.

(c)

If no transfers have been made to persons generally licensed under

3.5.5 during the reporting period, the report shall so indicate;

(6)

Report to NRC all transfers of industrial products or devices to persons for use

under NRC general license in Section 40.25 of 10 CFR Part 40.

(a)

Such report shall identify each general licensee by name and address,

an individual by name and/or position who may constitute a point of

contact between the agency and the general licensee, the type and

model number of device transferred, and the quantity of depleted

uranium contained in the product or device.

(b)

The report shall be submitted within 30 days after the end of each

calendar quarter in which such a product or device is transferred to the

generally licensed person.

(c)

If no transfers have been made to U.S. Nuclear Regulatory Commission

licensees during the reporting period, this information shall be reported to

NRC;

(7)

Report to the responsible State agency all transfers of devices manufactured and

distributed pursuant to 3.12.13 for use under a general license in that State's

regulations equivalent to 3.5.5,

(a)

Such report shall identify each general licensee by name and address,

an individual by name and/or position who may constitute a point of

contact between the agency and the general licensee, the type and

model number of device transferred, and the quantity of depleted

uranium contained in the product or device.

(b)

The report shall be submitted within 30 days after the end of each

calendar quarter in which such a product or device is transferred to the

generally licensed person.

(c)

If no transfers have been made general licensees within a particular

agreement state during the reporting period, this information shall be

reported to the responsible Agreement State agency upon the request of

that agency;

(8)

Keep records showing the name, address, and point of contact for each general

licensee to whom the specific licensee transfers depleted uranium in industrial

products or devices for use pursuant to the general license provided in 3.5.5 or

equivalent regulations of NRC or an Agreement State.

(a)

The records shall be maintained for a period of 2 years and shall show

the date of each transfer, the quantity of depleted uranium in each

product or device transferred, and compliance with the report

requirements of this section.

3.12.14 Registration of Product Information.

3.12.14.1

Any manufacturer or initial distributor of a sealed source or device containing a

sealed source may submit a request to the Department for evaluation of radiation safety

information about its product and for the product registration.

3.12.14.2

The request for review must be sent to the Radiation Program Manager,

Hazardous Materials and Waste Management Division, Colorado Department of Public

Health and Environment, 4300 Cherry Creek Drive South, Denver, Colorado 80246-1530.

3.12.14.3

The request for review of a sealed source or device must include sufficient

information about the design, manufacture, prototype testing, quality control program,

labeling, proposed uses and leak testing and, for a device, the request must also include

sufficient information about installation, service and maintenance, operating and safety

instructions, and its potential hazards, to provide reasonable assurance that the radiation

safety properties of the source or device are adequate to protect health and minimize

danger to life and property.

3.12.14.4

The Department normally evaluates a sealed source or device using radiation

safety criteria in accepted industry standards.

(1)

If these standards and criteria do not readily apply to a particular case, the

Department formulates reasonable standards and criteria with the help of the

manufacturer or distributor.

(2)

The Department shall use criteria and standards sufficient to ensure that the

radiation safety properties of the device or sealed source are adequate to protect

health and minimize danger to life and property. Subpart A of 10 CFR Part 32

includes specific criteria that apply to certain exempt products and 3.12.4, 3.12.5,

3.12.6, 3.12.8, and 3.12.9 of this part includes specific criteria applicable to

certain generally licensed devices. Sections 3.12.10 and 3.12.12 include specific

provisions that apply to certain specifically licensed items.

3.12.14.5

After completion of the evaluation, the Department issues a certificate of

registration to the person making the request. The certificate of registration

acknowledges the availability of the submitted information for inclusion in an application

for specific license proposing use of the product or concerning use under an exemption

from licensing or general license as applicable for the category of certificate.

3.12.14.6

The person submitting the request for evaluation and registration of safety

information about the product shall manufacture and distribute the product in accordance

with:

(1)

The statements and representations, including quality control program, contained

in the request; and

(2)

The provisions of the certificate of registration.

3.12.14.7

Authority to manufacture or initially distribute a sealed source or device to

specific licensees may be provided in the license without the issuance of a certificate of

registration in the following cases:

(1)

Calibration and reference sources containing no more than:

(a)

37 MBq (1 mCi), for beta and/or gamma emitting radionuclides; or

(b)

0.37 MBq (10 μCi), for alpha emitting radionuclides; or

(2)

The intended recipients are qualified by training and experience and have

sufficient facilities and equipment to safely use and handle the requested quantity

of radioactive material in any form in the case of unregistered sources or, for

registered sealed sources contained in unregistered devices, are qualified by

training and experience and have sufficient facilities and equipment to safely use

and handle the requested quantity of radioactive material in unshielded form, as

specified in their licenses; and

(a)

The intended recipients are licensed under 3.11 or comparable

provisions of NRC or an Agreement State; or

(b)

The recipients are authorized for research and development; or

(c)

The sources and devices are to be built to the unique specifications of

the particular recipient and contain no more than 740 GBq (20 Ci) of

tritium or 7.4 GBq (200 mCi) of any other radionuclide.

3.12.14.8

After the certificate is issued, the Department may conduct an additional review

as it determines is necessary to ensure compliance with current regulatory standards. In

conducting its review, the Department will complete its evaluation in accordance with

criteria specified in this section. The Department may request such additional information

as it considers necessary to conduct its review and the certificate holder shall provide the

information as requested.

3.12.15 Inactivation of certificates of registration of sealed sources and devices

3.12.15.1

A certificate holder who no longer manufactures or initially transfers any of the

sealed source(s) or device(s) covered by a particular certificate issued by the Department

shall request inactivation of the registration certificate. Such a request must be made to

the Department and must normally be made no later than two years after initial

distribution of all of the source(s) or device(s) covered by the certificate has ceased.

However, if the certificate holder determines that an initial transfer was in fact the last

initial transfer more than two years after that transfer, the certificate holder shall request

inactivation of the certificate within 90 days of this determination and briefly describe the

circumstances of the delay.

3.12.15.2

If a distribution license is to be terminated in accordance with 3.16 the licensee

shall request inactivation of its registration certificates associated with that distribution

license before the Department will terminate the license. Such a request for inactivation

of certificate(s) must indicate that the license is being terminated and include the

associated specific license number.

3.12.15.3

A specific license to manufacture or initially transfer a source or device covered

only by an inactivated certificate no longer authorizes the licensee to initially transfer such

sources or devices for use. Servicing of devices must be in accordance with any

conditions in the certificate, including in the case of an inactive certificate.

3.13

Third-Party Method.

3.13.1 If the applicant consents, the Department may enter into third party agreements for the applicant

to engage and pay for the services of a third party contractor to prepare the environmental impact

analysis required under 18.4 and/or to furnish an opinion of independent experts, satisfactory to

the Department, in respect to the completeness and adequacy of any information or data

furnished by the applicant and on any aspect of the applicant's project or effects thereof.

3.13.2 In proceeding under the third party agreement, the Department shall carry out the following

practices:

3.13.2.1

Such contractor shall be chosen solely by the Department.

3.13.2.2

The Department shall manage the contract.

3.13.2.3

The consultant shall be selected based on the consultant's ability relevant and

applicable work experience and an absence of conflict of interest. Third party contractors

will be required to execute a disclosure statement signifying they have no financial or

other conflicting interest in the outcome of the project.

3.13.2.4

The Department shall specify the information to be developed and supervise the

gathering, analysis and presentation of the information.

3.13.2.5

The Department shall have sole authority for approval and modification of the

statement, analysis, and conclusions included in third party's report.

3.13.3 When the license applicant pays for a third party agreement, the monies paid for the consultant

shall not be charged as part of the fees required under Part 12.

3.14

Issuance of a Specific License.

3.14.1 Upon a determination that an application meets the requirements of the Act and the regulations of

the Department, the Department will issue a specific license authorizing the proposed activity in

such form and containing such conditions and limitations as it deems appropriate or necessary.

3.14.2 The Department may incorporate in any license at the time of issuance, or thereafter by

appropriate rule, regulation, or order, such additional requirements and conditions with respect to

the licensee's receipt, possession, use, and transfer of radioactive material subject to this part, as

it deems appropriate or necessary in order to:

3.14.2.1

Minimize danger to public health and safety or property;

3.14.2.2

Require such reports and the keeping of such records, and to provide for such

inspections of activities under the license as may be appropriate or necessary; and

3.14.2.3

Prevent loss or theft of material subject to this part.

3.14.3 Whenever the Department denies an application for a new license or a license renewal, the

Department will notify the applicant in writing stating the grounds for denial

3.14.3.1

Upon denial, the applicant may request a hearing pursuant to Sections 24-4-104

and 24-4-105, CRS.

3.15

Specific Terms and Conditions of License.

3.15.1 Each license issued pursuant to this part shall be subject to all the provisions of the Act, now or

hereafter in effect, and to all rules, regulations, and orders of the Department.

3.15.2 Inalienability of Licenses.

3.15.2.1

No license issued or granted under this part and no right to possess or utilize

radioactive material granted by any license issued pursuant to this part shall be

transferred, assigned, or in any manner disposed of, either voluntarily or involuntarily,

directly or indirectly, through transfer of control of any license to any person unless the

Department shall, after securing full information, find that the transfer is in accordance

with the provisions of the Act, now or hereafter in effect, and to all valid rules, regulations,

and orders of the Department, and shall give its consent in writing.

3.15.2.2

An application for transfer of license must include:

(1)

The identity, technical and financial qualifications of the proposed transferee;

(2)

Financial assurance for decommissioning information required by 3.9.6;

(3)

A description of the acquisition or proposed transfer including dates;

(4)

An updated organizational chart including the proposed transferee’s

management structure for the licensed activities;

(5)

Documentation of registration with the Colorado Secretary of State for the

proposed transferee;

(6)

A statement from the proposed transferee's management that they will conduct

business in accord with all of the commitments previously submitted by the

current licensee;

(7)

A statement from the proposed transferee's management accepting liability for all

licensed materials that are and have been possessed under the license; and

(8)

A copy of the appropriate radioactive materials license application signed by the

RSO and the proposed transferee's management.

3.15.3 Each person licensed by the Department pursuant to this part shall confine use and possession

of the material licensed to the locations and purposes authorized in the license. Except as

otherwise provided in the license, a license issued pursuant to Part 3 shall carry with it the right to

receive, possess, and use source or byproduct material. Preparation for shipment and transport

of source or radioactive material shall be in accordance with the provisions of Part 17.

3.15.4 Notice and Disposition of Records Prior to License Termination.

3.15.4.1

Each licensee shall notify the Department in writing when the licensee decides to

permanently discontinue all activities involving materials authorized under the license.

3.15.4.2

Prior to license termination, each licensee authorized to possess radioactive

material with a half-life greater than 120 days, in an unsealed form, shall forward the

following records to the Department.

(1)

Records of disposal required by 4.48; and

(2)

Records of surveys required by 4.42.

3.15.4.3

If licensed activities are transferred or assigned in accordance with 3.15.2, each

licensee authorized to possess radioactive material, with a half-life greater than 120 days,

in an unsealed form, shall transfer the records required in 3.15.4.2 to the new licensee

and the new licensee will be responsible for maintaining these records until the license is

terminated.

3.15.4.4

Prior to license termination, each licensee shall forward the records required by

3.16.5 to the Department.

3.15.5 Bankruptcy.

3.15.5.1

Each specific licensee and each general license that is required to register by

3.6.4.3 of this part shall notify the Department in writing immediately following the filing of

a voluntary or involuntary petition for bankruptcy under any Chapter of Title 11

(Bankruptcy) of the United States Code by or against:

(1)

The licensee;

(2)

An entity (as that term is defined in 11 U.S.C. 101(15)) controlling the licensee or

listing the license or licensee as property of the estate; or

(3)

An affiliate (as that term is defined in 11 U.S.C. 101(2)) of the licensee.

3.15.5.2

The notification specified in 3.15.5.1 shall include the bankruptcy court in which

the petition for bankruptcy was filed and the date of the filing of the petition.

3.15.6 Each licensee preparing technetium-99m radiopharmaceuticals from molybdenum-99/technetium-

99m generators or rubidium-82 from strontium-82/rubidium-82 generators shall test the generator

eluates for molybdenum-99 breakthrough or strontium-82 and strontium-85 contamination,

respectively, in accordance with Part 7. The licensee shall record the results of each test and

retain each record for 3 years after the record is made. The licensee shall report the results of

any test that exceeds the permissible concentration listed in Part 7, Section 7.33.1 at the time of

generator elution, in accordance with Part 7, Section 7.33.5.

3.15.7 Authorization under 3.8.10 to produce Positron Emission Tomography (PET) radioactive drugs for

noncommercial transfer to medical use licensees in its consortium does not relieve the licensee

from complying with applicable FDA, other Federal, and State requirements governing radioactive

drugs.

3.15.7.1

Each licensee authorized under 3.8.10 to produce PET radioactive drugs for

noncommercial transfer to medical use licensees in its consortium shall:

(1)

Satisfy the labeling requirements in 3.12.10.1(4) for each PET radioactive drug

transport radiation shield and each syringe, vial, or other container used to hold a

PET radioactive drug intended for noncommercial distribution to members of its

consortium.

(2)

Possess and use instrumentation to measure the radioactivity of the PET

radioactive drugs intended for noncommercial distribution to members of its

consortium and meet the procedural, radioactivity measurement, instrument test,

instrument check, and instrument adjustment requirements in 3.12.10.3.

3.15.7.2

A licensee that is a pharmacy authorized under 3.8.10 to produce PET

radioactive drugs for noncommercial transfer to medical use licensees in its consortium

shall require that any individual that prepares PET radioactive drugs shall be:

(1)

An authorized nuclear pharmacist that meets the requirements in 3.12.10.2(2),

or

(2)

An individual under the supervision of an authorized nuclear pharmacist as

specified in Part 7, Section 7.10.

3.15.7.3

A pharmacy, authorized under 3.8.10 to produce PET radioactive drugs for

noncommercial transfer to medical use licensees in its consortium that allows an

individual to work as an authorized nuclear pharmacist, shall meet the requirements of

3.12.10.2(5).

3.16

Expiration, Decommissioning and Termination of Licenses.

3.16.1 Definition of “principal activity”.

3.16.1.1

As used in this regulation, “principal activity” means an activity authorized by the

license which is essential to achieving the purpose(s) for which the license was issued or

amended.

3.16.1.2

Not included as principal activities are:

(1)

Radioactive material storage while no licensed material is accessed for use or

disposal; and

(2)

Any activity incidental to decontamination or decommissioning.

3.16.2 Expiration.

3.16.2.1

Except as provided in 3.17.2, each specific license shall expire at the end of the

specified day in the month and year stated therein.

3.16.2.2

Each specific license revoked by the Department expires at the end of the day on

the date of final determination to revoke the license, or on the expiration date stated in

the determination, or as otherwise provided by order.

3.16.2.3

With respect to possession of radioactive material and residual radioactive

contamination, each specific license continues in effect beyond the expiration date until

the Department notifies the licensee in writing that the license is terminated, even if:

(1)

The licensee decides not to renew the license;

(2)

No application for license renewal is submitted;

(3)

An application for renewal is denied; or

(4)

The Department modifies or suspends a license.

3.16.2.4

No less than 30 days before the expiration date specified in the license, the

licensee shall either:

(1)

Submit an application for license renewal under 3.17; or

(2)

Notify the Department, in writing, that the licensee has decided not to renew the

license.

3.16.2.5

If a licensee does not submit an application for license renewal under 3.17, the

licensee shall, on or before the expiration date specified in the license:

(1)

Terminate use of radioactive material;

(2)

Transfer radioactive materials to an authorized recipient and/or properly dispose

of radioactive material;

(3)

Reduce residual radioactive contamination to levels which are as low as

reasonably achievable (ALARA); and

(4)

Submit a completed Department Form R-23, Request for Termination of a

Radioactive Materials License, or equivalent information requesting license

termination, including survey results, leak tests, disposal records, and/or other

documentation which demonstrates acceptable conditions for license termination

as specified in 3.16.6.

3.16.2.6

Each licensee who possesses radioactive material, including residual radioactive

contamination attributable to licensed activities, following the expiration date specified in

the license shall:

(1)

Limit actions involving radioactive material to those related to decontamination

and other activities related to preparation for release for unrestricted use; and

(2)

Continue to control entry to restricted areas until they are suitable for release for

unrestricted use or the Department notifies the licensee in writing that the license

is terminated.

3.16.2.7

Each licensee or person responsible for a facility or site which includes a non-

exempt source of radiation or which may be contaminated by residual radioactivity shall,

no less than 30 days before vacating or relinquishing possession or control of the facility

or site, notify the Department, in writing, of the intent to vacate.

3.16.3 Timely Decommissioning.

3.16.3.1

Each licensee or person in possession of a non-exempt source of radiation who

decides to terminate all activities involving that source of radiation shall notify the

hazardous materials and waste management division immediately, in writing.

3.16.3.2

The licensee shall notify the Hazardous Materials And Waste Management

Division in writing within 60 days of the occurrence of any of the following:

(1)

The licensee has decided to permanently cease principal activities, as defined in

this part, at the entire site or in any separate building or outdoor area that

contains residual radioactivity such that the building or outdoor area is unsuitable

for unrestricted use in accordance with 4.61; or

(2)

No principal activities under the license have been conducted for a period of 24

months; or

(3)

No principal activities have been conducted for a period of 24 months in any

separate building or outdoor area that contains residual radioactivity such that

the building or outdoor area is unsuitable for unrestricted use in accordance with

these regulations.

3.16.3.3

Concurrent with the notification of the Hazardous Materials And Waste

Management Division required in 3.16.3.1 and 3.16.3.2, the licensee shall either:

(1)

Begin decommissioning activities; or,

(2)

Within 12 months of notification, submit a decommissioning plan if required by

3.16.4, and begin decommissioning upon approval of that plan.

3.16.3.4

Licensees shall complete decommissioning of the site or separate building or

outdoor area as soon as practicable but no later than 24 months following the initiation of

decommissioning, unless an alternate schedule addressing the factors in 3.16.4 is

requested and approved by the Department.

3.16.3.5

When decommissioning involves the entire site, the licensee shall request

license termination upon completion of decommissioning activities.

3.16.3.6

The Department may approve alternate schedules for the submission of plans

and for the completion of decommissioning as required pursuant to 3.16.3.3 and 3.16.3.4

if the Department determines that the alternate schedule:

(1)

Is necessary to effectively conduct decommissioning;

(2)

Presents no undue risks to public health and safety; and

(3)

Is otherwise in the public interest.

3.16.4 Decommissioning Plan.

3.16.4.1

A licensee must submit a decommissioning plan:

(1)

If the licensee intends to terminate the license using radiological criteria specified

in 4.61.3 or 4.61.4 (the exemption of 4.61.1.1 applies);

(2)

If required otherwise by these regulations;

(3)

If required by license condition; or

(4)

If the procedures and activities necessary to carry out decommissioning of the

site or separate building or outdoor area have not been previously approved by

the Department and these procedures could increase potential health and safety

impacts to workers or to the public, such as in any of the following cases:

(a)

Procedures would involve techniques not applied routinely during

cleanup or maintenance operations;

(b)

Workers would be entering areas not normally occupied where surface

contamination and radiation levels are significantly higher than routinely

encountered during operation;

(c)

Procedures could result in significantly greater airborne concentrations of

radioactive materials than are present during operation; or

(d)

Procedures could result in significantly greater releases of radioactive

material to the environment than those associated with operation.

3.16.4.2

Procedures such as those listed in 3.16.4.1 of this section with potential health

and safety impacts may not be carried out prior to Department approval of the

decommissioning plan.

3.16.4.3

The decommissioning plan for the site or separate building or outdoor area must

include:

(1)

A description of the conditions of the site, separate buildings, and/or outdoor

areas sufficient to evaluate the acceptability of the plan;

(2)

A description of planned decommissioning activities and a schedule for

completion;

(3)

A description of methods used to ensure protection of workers and the

environment against radiation hazards during decommissioning;

(4)

A description of the planned final radiation survey;

(5)

A current detailed cost estimate for decommissioning, comparison of that

estimate with present funds set aside for decommissioning, and a plan for

assuring the availability of adequate funds for completion of decommissioning;

and

(6)

A description of the intended final condition of the site, separate buildings, and/or

outdoor areas upon completion of decommissioning activities.

(7)

Decommissioning plans proposing the use of radiological criteria specified in

4.61.3 or 4.61.4, must also include:

(a)

An analysis demonstrating that reductions in residual radioactivity

necessary to comply with the provisions of 4.61.2 would result in net

public or environmental harm or were not being made because the

residual levels of contamination associated with restricted conditions are

ALARA.

(i)

Determination of dose and residual radioactivity levels which are

ALARA must take into

This text is long and has been trimmed here. Open the source document for the complete record.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.